{
  "dataset": "crash_2",
  "total_mechanisms_analyzed": 15,
  "total_abstracts_retrieved": 212,
  "overall_support_count": 10,
  "overall_conflict_count": 3,
  "overall_neutral_count": 199,
  "mechanism_results": [
    {
      "feature_name": "iage",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Younger patients generally have a higher physiological reserve, which may allow them to benefit more from interventions that support hemostatic stability, like TXA.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"iage\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"interventions\" OR \"physiological\" OR \"hemostatic\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 0,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 0,
      "abstracts_analyzed": []
    },
    {
      "feature_name": "iage",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "The efficacy of fibrinolytic inhibitors like TXA might be enhanced in patients with a more robust clotting function, typically seen in younger demographics.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"iage\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"fibrinolytic\" OR \"demographics\" OR \"inhibitors\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 0,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 0,
      "abstracts_analyzed": []
    },
    {
      "feature_name": "iage",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Studies indicate that age is an independent predictor of mortality in trauma patients; thus, younger age may enhance the relative benefit of interventions targeting hemodynamic stability.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"iage\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"interventions\" OR \"independent\" OR \"hemodynamic\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 0,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 0,
      "abstracts_analyzed": []
    },
    {
      "feature_name": "isbp",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Hypotension is often indicative of severe active bleeding, where hemostatic support is critical to prevent mortality.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"systolic blood pressure\" OR \"blood pressure\" OR \"initial blood pressure\" OR hypotension) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"hypotension\" OR \"hemostatic\" OR \"indicative\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 4,
      "conflict_count": 1,
      "neutral_count": 15,
      "support_percentage": 20.0,
      "conflict_percentage": 5.0,
      "support_ratio": 0.2,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses orthostatic hypotension as a hemodynamic phenomenon, its subtypes, causes (neurogenic vs non\u2011neurogenic), clinical presentations, and largely non\u2011pharmacologic management. It does not link hypotension to severe active bleeding, mortality risk from hemorrhage, or the need for hemostatic support. Therefore it neither supports nor contradicts the proposed mechanism about hypotension as an indicator of severe bleeding requiring hemostatic intervention.",
          "key_findings": "Orthostatic hypotension is defined as a large blood pressure drop on standing; subtypes are described (initial, delayed recovery, classic, delayed); it is associated with adverse outcomes and varied symptoms (falls, presyncope, syncope); causes can be neurogenic (e.g., early Parkinson\u2019s/synucleinopathies) or non\u2011neurogenic; management is primarily non\u2011pharmacological and tailored, including stopping BP\u2011lowering drugs and lifestyle measures. No mention is made of bleeding, hemorrhage, or hemostatic treatment.",
          "pmid": "35841911",
          "title": "Diagnosis and treatment of orthostatic hypotension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract mentions hemodynamic monitoring and blood pressure augmentation after traumatic spinal cord injury but does not link hypotension specifically to severe active bleeding, nor does it discuss hemostatic support or mortality related to bleeding.",
          "key_findings": "Following diagnosis of traumatic spinal cord injury, interventions include hemodynamic monitoring in the ICU and blood pressure augmentation. No mention is made of hypotension as a marker of severe active bleeding, nor of hemostatic therapies or bleeding-related outcomes.",
          "pmid": "28447605",
          "title": "Traumatic spinal cord injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The mechanism states that hypotension in trauma often reflects severe active bleeding where hemostatic (blood product/coagulation-focused) support is critical to prevent mortality. The abstract describes traumatic hemorrhagic shock, noting that hypotension arises after an initial compensatory phase and that persistent hypotension and hypoperfusion worsen coagulopathy and organ function. It explicitly identifies core resuscitation goals as restoring intravascular volume with a balanced ratio of blood products and correcting pathologic coagulopathy, aligning with the idea that in hypotensive bleeding patients hemostatic support is central to preventing adverse outcomes. While the article\u2019s main focus is on vasopressors, its pathophysiological description and stated resuscitation objectives are consistent with the proposed mechanism.",
          "key_findings": "1) Traumatic shock involves an initial sympathoexcitatory, vasoconstrictive phase maintaining blood pressure despite acute blood loss, followed by a sympathoinhibitory vasodilation phase in which hypotension is observed.\n2) The objectives of hemodynamic resuscitation in hypotensive trauma patients include restoring adequate intravascular volume with a balanced ratio of blood products and correcting pathologic coagulopathy, along with maintaining organ perfusion.\n3) Persistent hypotension and hypoperfusion are associated with worse coagulopathy and worse organ function.\n4) Excessive volume resuscitation is harmful, so resuscitation must balance volume and vascular tone, but the core early goals emphasize blood products and correction of coagulopathy in hypotensive, bleeding trauma patients.",
          "pmid": "33908898",
          "title": "Vasopressors in Trauma: A Never Event?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses orthostatic hypotension in Parkinson's disease as a manifestation of autonomic dysfunction and outlines diagnostic and management strategies. It does not link hypotension to severe active bleeding, hemostatic status, or mortality prevention via hemostatic support. Thus, it neither supports nor contradicts the proposed mechanism that hypotension is often indicative of severe active bleeding requiring hemostatic intervention.",
          "key_findings": "Orthostatic hypotension in Parkinson's disease is described as due to impaired sympathetic nerve activity (neurogenic) or non-neurogenic causes such as hypovolemia and BP-lowering drugs. Diagnosis is based on supine and standing blood pressure measurements and autonomic testing. Management emphasizes correction of non-neurogenic causes, lifestyle and non-pharmacologic measures, with pharmacologic agents used stepwise for persistent symptoms. About 50% of patients with neurogenic OH also have supine and nocturnal hypertension, which must be monitored and managed. Untreated OH increases risk of syncope and falls; supine hypertension raises risk of hypertensive emergencies and end-organ damage. No discussion is made of bleeding, hemostatic support, or hypotension as a marker of hemorrhage.",
          "pmid": "32716319",
          "title": "Management of Orthostatic Hypotension in Parkinson's Disease.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses orthostatic hypotension in the context of autonomic dysfunction and hypertension management but does not address hypotension as a marker of severe active bleeding or the need for hemostatic support. There is no mention of bleeding, hemorrhage, or hemostatic interventions, so it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "Orthostatic hypotension is described as a common comorbidity of hypertension linked to autonomic dysfunction and blood pressure regulation; management focuses on characterizing patterns and triggers, adjusting medications, and using measures such as countermaneuvers and short-acting vasoactive agents. No evidence is presented relating hypotension to severe bleeding or hemostatic support.",
          "pmid": "38205630",
          "title": "Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates different perioperative blood pressure management strategies and their effect on major vascular complications, not on active bleeding, hemostasis, or mortality from hemorrhage. It does not analyze hypotension as a marker of severe active bleeding or discuss hemostatic support, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "In a randomized trial of 7,490 noncardiac surgery patients on long-term antihypertensives, a hypotension-avoidance strategy (higher intraoperative MAP target, withholding some antihypertensives) and a hypertension-avoidance strategy (lower MAP target, continuation of antihypertensives) resulted in similar rates of a composite outcome of vascular death, nonfatal myocardial injury, stroke, and cardiac arrest at 30 days (13.9% vs. 14.0%; HR 0.99, 95% CI 0.88\u20131.12). The study does not report outcomes specifically related to bleeding, hemorrhagic shock, or need for hemostatic support.",
          "pmid": "37094336",
          "title": "Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism links hypotension to severe active bleeding requiring hemostatic support to prevent mortality. This trial examines intraoperative blood pressure targets and their impact on postoperative organ injury and mortality in high\u2011risk abdominal surgery patients, but it does not assess active bleeding, hemorrhagic shock, or the role of hemostatic support. The study\u2019s focus is on individualized vs routine MAP targets and composite ischemic outcomes, not on hypotension as a marker of severe bleeding or the need for hemostatic intervention.",
          "key_findings": "In a randomized trial of 1142 high\u2011risk patients undergoing major abdominal surgery, individualized perioperative blood pressure management based on preoperative nighttime MAP did not reduce the incidence of a composite outcome (acute kidney injury, acute myocardial injury, nonfatal cardiac arrest, or death within 7 days) compared with routine management targeting MAP \u226565 mm Hg. None of 22 secondary outcomes, including infectious complications and a 90\u2011day composite (kidney replacement therapy, myocardial infarction, nonfatal cardiac arrest, or death), differed significantly between groups. The abstract does not report data on active bleeding, hemorrhage severity, or hemostatic support.",
          "pmid": "41076588",
          "title": "Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract is a broad review of recent advances in intracerebral hemorrhage, mentioning hemostatic therapies and acute blood pressure lowering, but it does not discuss hypotension, its relationship to severity of bleeding, or its role as an indicator that hemostatic support is critical to prevent mortality.",
          "key_findings": "The review covers risk factors, imaging predictors and scores for hematoma expansion, hemostatic therapies, acute blood pressure lowering, intraventricular alteplase, and surgical therapies in spontaneous intracerebral hemorrhage, without specific mention of hypotension or its prognostic/therapeutic significance in relation to active bleeding and hemostatic support.",
          "pmid": "30906532",
          "title": "Recent advances in spontaneous intracerebral hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism is that hypotension reflects severe active bleeding for which hemostatic support is critical to prevent mortality. This trial includes hypotensive trauma patients with presumed haemorrhagic shock and tests whether early prehospital hemostatic support (PRBC + lyophilized plasma) improves lactate clearance and mortality versus saline. It found no superiority of blood products over saline, but it does not question that hypotension signals severe bleeding, nor does it show that hemostatic support is unimportant overall (patients later received in-hospital care). Thus it neither validates nor refutes the mechanistic claim about hypotension as an indicator of severe bleeding and the critical importance of hemostatic support for mortality prevention.",
          "key_findings": "1) Adults with trauma-related haemorrhagic shock and hypotension (SBP <90 mm Hg or absent radial pulse) were randomized prehospital to PRBC + lyophilised plasma vs 0.9% saline.\n2) The composite primary outcome (episode mortality or impaired lactate clearance) occurred in 64% of the PRBC-LyoPlas group vs 65% of the saline group, with no significant difference (adjusted risk difference ~0%, p=0.996).\n3) Transfusion-related complications and serious adverse events were similar between groups; no treatment-related deaths were reported.\n4) Authors conclude that prehospital PRBC-LyoPlas resuscitation was not shown to be superior to saline for these hypotensive trauma patients, and further work is needed to identify which patients benefit from prehospital transfusion.",
          "pmid": "35271808",
          "title": "Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses management of intracerebral haemorrhage, including early blood pressure control and reversal of coagulopathy, but it does not mention hypotension, its relationship to bleeding severity, or the use of hypotension as an indicator for hemostatic support. Therefore it neither supports nor contradicts the specific mechanistic claim about hypotension as a marker of severe active bleeding requiring hemostatic support.",
          "key_findings": "The abstract states that intracerebral haemorrhage outcomes are related to haematoma site, mass effect, intracranial pressure, perihaematomal oedema, and complications of prolonged neurological dysfunction. It notes moderate evidence for benefits of active management including specialist stroke care, targeted neurointensive and surgical interventions, early control of elevated blood pressure, and rapid reversal of abnormal coagulation. Hypotension and its role in indicating severe bleeding or guiding hemostatic support are not addressed.",
          "pmid": "30319113",
          "title": "Intracerebral haemorrhage: current approaches to acute management.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on thunderclap headache, its differential diagnosis, and related intracranial pathologies. It does not mention systemic hypotension, severity of bleeding as reflected by blood pressure, or the need for hemostatic support in relation to hypotension. Therefore, it neither supports nor contradicts the proposed mechanism linking hypotension with severe active bleeding and the critical need for hemostatic support.",
          "key_findings": "Thunderclap headache is described as a sudden, severe head pain that can be the first sign of various intracranial conditions, including subarachnoid haemorrhage and other vascular or structural brain disorders. The abstract discusses diagnostic criteria, differential diagnosis, and reversible cerebral vasoconstriction syndrome, but does not address blood pressure, hypotension, bleeding severity, or hemostatic management.",
          "pmid": "16781992",
          "title": "Thunderclap headache.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The abstract explicitly links control of bleeding and hemostatic resuscitation with survival in trauma, and describes permissive hypotension management while emphasizing that prehospital damage control measures for bleeding are critical to increase survival. This aligns with the proposed mechanism that hypotension in the trauma/bleeding context signifies a state where hemostatic support is crucial to prevent mortality. Although it does not provide quantitative outcome data tied specifically to hypotension thresholds, its recommendations and conclusions conceptually support the mechanism.",
          "key_findings": "1) The article states that damage control resuscitation, including bleeding control and initiation of hemostatic resuscitation, should be started as soon as possible after trauma to avoid high mortality rates. 2) It emphasizes that prehospital damage control measures, which are focused on controlling bleeding (e.g., tourniquet use) and early hemostatic resuscitation, are the first steps in bleeding control and are key to increasing survival in severe trauma. 3) It recommends permissive hypotension with systolic blood pressure between 80\u201390 mm Hg in the setting of trauma resuscitation, implying hypotension management is directly tied to hemorrhage control and survival.",
          "pmid": "33795898",
          "title": "Prehospital Damage Control: The Management of Volume, Temperature\u2026 and Bleeding!",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The proposed mechanism states that hypotension is often a marker of severe active bleeding where hemostatic support is critical to prevent mortality. The abstract specifically studies trauma patients with hemorrhagic shock (i.e., active bleeding) and compares different blood pressure targets during resuscitation. It shows that a strategy of permissive hypotension in this bleeding context is associated with improved survival, reduced blood loss, and reduced blood product utilization compared with conventional higher-pressure resuscitation. This supports the idea that in the setting of severe bleeding, careful management recognizing hypotension and limiting aggressive fluids (a hemostasis-preserving strategy) is critical to reducing mortality. While the mechanism emphasizes hypotension as an indicator for hemostatic support rather than the exact BP targets, the data directly link the hypotensive bleeding state, resuscitation approach, and mortality outcomes, aligning with the core mechanistic concept that management of hypotension in active hemorrhage is crucial for survival.",
          "key_findings": "In adult trauma patients with hemorrhagic shock, randomized controlled trials comparing permissive hypotension (SBP 50\u201370 mmHg or MAP \u226550 mmHg) to conventional resuscitation (SBP 65\u2013100 mmHg or MAP \u226565 mmHg) showed: (1) pooled odds ratio for 30-day or in-hospital mortality of 0.70 (95% CI 0.53\u20130.92) favoring permissive hypotension; (2) patients in the permissive hypotension groups received fewer blood products; (3) patients in these groups had lower estimated blood loss. These results indicate that the way hypotension is managed in the context of active hemorrhage significantly affects bleeding and mortality.",
          "pmid": "29370058",
          "title": "Permissive hypotension versus conventional resuscitation strategies in adult trauma patients with hemorrhagic shock: A systematic review and meta-analysis of randomized controlled trials.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines the effect of a Chinese heart-healthy diet on lowering elevated blood pressure in adults, not hypotension or acute bleeding. It does not address blood loss, hemorrhage, hemodynamic instability, or the need for hemostatic support in the context of hypotension, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "A cuisine-based Chinese heart-healthy diet reduced systolic blood pressure by an additional 10 mm Hg and diastolic blood pressure by 3.8 mm Hg compared with a control diet over 28 days, with no increase in adverse events and good palatability and cost-effectiveness. The study population had mildly elevated baseline blood pressure and no discussion of hypotension or bleeding.",
          "pmid": "35861850",
          "title": "Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "high",
          "reasoning": "The abstract explicitly links severe hemorrhagic shock (a state often involving hypotension) with life-threatening bleeding and emphasizes that rapid hemorrhage control and targeted hemostatic therapy are crucial to improve outcomes. It further highlights coagulation management, early administration of tranexamic acid and fibrinogen, optimized transfusion strategies, and use of reversal agents as key components of treatment in hemorrhagic shock, directly supporting the idea that hemostatic support is critical in the context of severe bleeding associated with hypotension/shock.",
          "key_findings": "1) Hypovolemic and hemorrhagic shock are life-threatening conditions resulting from significant blood loss that rapidly lead to multi-organ failure and death if untreated. 2) Rapid diagnosis, early hemorrhage control, and targeted hemodynamic and hemostatic therapy are described as crucial to improve outcomes. 3) In hemorrhagic shock, coagulation management is said to be of paramount importance. 4) Early goal-directed administration of tranexamic acid and fibrinogen and optimized transfusion strategies (including specific RBC:plasma:platelet ratios) are recommended to stabilize coagulation and restore hemostasis.",
          "pmid": "40086861",
          "title": "[Hypovolaemic and haemorrhagic shock].",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates how intensive antihypertensive treatment affects orthostatic hypertension prevalence. It does not address hypotension as a marker of severe active bleeding, the need for hemostatic support, or bleeding-related mortality. The mechanisms investigated are blood pressure regulation with posture and treatment intensity, not hemorrhage or hemostasis.",
          "key_findings": "In a pooled analysis of 31,124 hypertensive adults from nine trials, orthostatic hypertension was common (17%) and more intensive blood pressure treatment modestly reduced its occurrence compared with less intensive treatment (odds ratio 0.93, 95% CI 0.90\u20130.96). Effects varied by race and diabetes status but not by age, sex, baseline BP, obesity, kidney disease, stroke, cardiovascular disease, or pre-randomization orthostatic hypertension.",
          "pmid": "40132860",
          "title": "Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "conflict",
          "confidence": "medium",
          "reasoning": "The proposed mechanism assumes hypotension in severe bleeding indicates a need for aggressive hemostatic support to prevent mortality, implicitly linking correction of hypotension (restoration of normal systemic pressure) with better outcomes. The abstract instead highlights that aiming for normotension by restoring intravascular volume can increase blood loss and potentially worsen mortality, and notes growing evidence that hypotensive (permissive) resuscitation improves long-term survival. This contradicts the notion that hypotension in active bleeding should routinely be corrected to normal pressures to prevent death.",
          "key_findings": "1) In trauma patients, restoring intravascular volume to achieve normal systemic pressure risks increasing blood loss and potentially affecting mortality negatively. 2) Growing evidence, mainly from animal studies, suggests that hypotensive resuscitation results in improved long-term survival. 3) The review focuses on concepts (deliberate hypotension, delayed resuscitation, permissive hypotension) that intentionally maintain subnormal pressures to reduce blood loss rather than fully correcting hypotension.",
          "pmid": "11092054",
          "title": "Permissive hypotension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses fluid resuscitation strategies, permissive hypotension, and blood pressure targets in trauma-induced hemorrhagic shock, but it does not explicitly state that hypotension itself is often indicative of severe active bleeding nor that hemostatic support is the critical intervention to prevent mortality. It focuses on how aggressively to correct hypotension and with what fluids/vasopressors, not on hypotension as a diagnostic marker of severe bleeding or on hemostatic therapy as the key response.",
          "key_findings": "The review notes that: (1) crystalloid-based resuscitation is being reassessed due to potential for increased bleeding and coagulopathy; (2) current guidelines recommend titrated fluids and vasopressors to minimal blood pressure targets until hemorrhage is controlled, with higher blood pressure targets in traumatic brain injury; (3) evidence supporting specific fluid types, volumes, and protocols is limited; and (4) emerging monitoring and diagnostic technologies and further research are needed to optimize trauma care. None of these directly address hypotension as an indicator of severe active bleeding requiring hemostatic support to prevent mortality.",
          "pmid": "39695790",
          "title": "Are crystalloid-based fluid expansion strategies still relevant in the first hours of trauma induced hemorrhagic shock?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses resuscitation strategies for hemorrhaging patients, including permissive hypotension and hemostatic resuscitation, but it does not specifically state that hypotension is indicative of severe active bleeding nor that hypotension itself is used as a marker to trigger hemostatic support to prevent mortality. It focuses on managing the physiologic derangements of hemorrhage rather than using hypotension as an indicator of bleeding severity.",
          "key_findings": "The abstract describes damage control resuscitation for hemorrhaging patients, including permissive hypotension, high ratios of plasma and platelet transfusion to packed red blood cells, limitation of crystalloid, and early hemorrhage control. It notes that these strategies, plus adjuncts like thrombelastography, tranexamic acid, and activated factor VII, have improved outcomes. However, it does not explicitly link hypotension as an indicator of severe active bleeding requiring hemostatic support.",
          "pmid": "25385695",
          "title": "Damage Control Resuscitation.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses intraoperative hypotension, its association with postoperative complications, and strategies to prevent or treat low blood pressure. However, it does not address hypotension specifically as an indicator of severe active bleeding, nor does it evaluate hemostatic support or bleeding-related mortality. Thus it neither supports nor contradicts the proposed mechanism linking hypotension to severe bleeding where hemostatic support is critical.",
          "key_findings": "The systematic review of 48 randomized controlled trials (N = 46,377) found that various blood pressure optimization strategies (hemodynamic protocols, withholding antihypertensives, continuous monitoring, and adjuvant agents like vasopressors) reduced intraoperative exposure to hypotension. Low blood pressure alarms had inconsistent effects. There was limited evidence that higher intraoperative BP targets reduced complications; overall, data were insufficient to conclude that optimization strategies improve postoperative outcomes. Bleeding, hemostasis, or hemostatic support were not specifically examined.",
          "pmid": "38870081",
          "title": "Intraoperative Hypotension in Patients Having Major Noncardiac Surgery Under General Anesthesia: A Systematic Review of Blood Pressure Optimization Strategies.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "isbp",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "TXA works by inhibiting fibrinolysis, which is crucial in patients with excessive bleeding, often marked by low blood pressure.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"systolic blood pressure\" OR \"blood pressure\" OR \"initial blood pressure\" OR hypotension) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"fibrinolysis\" OR \"inhibiting\" OR \"excessive\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses vasopressor use, vasoconstriction, vascular tone, and blood pressure management in traumatic shock but does not mention tranexamic acid (TXA), fibrinolysis, or any antifibrinolytic mechanisms. It focuses on hemodynamic resuscitation rather than coagulation or fibrinolytic pathways, so it neither supports nor contradicts the proposed mechanism of TXA working via inhibition of fibrinolysis in hypotensive bleeding patients.",
          "key_findings": "The article describes: (1) concerns that vasopressors may worsen organ perfusion and outcomes in hypotensive trauma patients; (2) the complex pathophysiology of traumatic shock with an initial vasoconstrictive, sympathoexcitatory phase followed by a vasodilatory, sympathoinhibitory phase; (3) goals of resuscitation including restoring intravascular volume, correcting coagulopathy, and maintaining organ perfusion; and (4) advocacy for a nuanced, balanced approach to vasopressor use. No data are presented regarding TXA, fibrinolysis, or direct links between low blood pressure, bleeding, and antifibrinolytic therapy.",
          "pmid": "33908898",
          "title": "Vasopressors in Trauma: A Never Event?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses endothelial dysfunction, hypertension, vascular tone regulation, and therapeutic targets for hypertension, but it does not mention tranexamic acid, fibrinolysis, antifibrinolytic mechanisms, or bleeding/low blood pressure contexts. Therefore, it neither supports nor contradicts the proposed mechanism that TXA works by inhibiting fibrinolysis in patients with excessive bleeding and hypotension.",
          "key_findings": "Endothelium regulates vascular tone, cell growth, and interactions with leukocytes and thrombocytes; endothelial dysfunction contributes to hypertension and other cardiovascular diseases; antihypertensive therapies may affect endothelial dysfunction; and endothelial mechanisms are important therapeutic targets in hypertension. No discussion of TXA, fibrinolysis, or bleeding-related hypotension is provided.",
          "pmid": "28035582",
          "title": "Endothelial Dysfunction and Hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses arterial stiffness, hypertension, vascular aging, and effects of various cardiovascular drugs on arterial stiffness. It does not mention tranexamic acid (TXA), fibrinolysis, antifibrinolytic mechanisms, or bleeding/low blood pressure contexts, so it neither supports nor conflicts with the proposed TXA mechanism.",
          "key_findings": "Arterial stiffness is a marker of cardiovascular risk in hypertension; it is influenced by blood pressure, age, vascular structure, and risk factor exposure. Stiffness affects brain, kidney, and heart function and participates in a feedback loop increasing blood pressure and stiffness. Antihypertensive, lipid-lowering, antidiabetic, and anti-inflammatory drugs can reduce stiffness, sometimes independent of blood pressure. No data relate to TXA, fibrinolysis, or hemorrhagic states.",
          "pmid": "33793325",
          "title": "Arterial Stiffness and Cardiovascular Risk in Hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses general neurocritical care aspects of ischemic stroke, including fibrinolytic reversal and blood pressure goals, but it does not mention tranexamic acid (TXA), its mechanism, or provide data on inhibition of fibrinolysis in relation to hypotensive bleeding patients.",
          "key_findings": "Reviews ICU care for ischemic stroke: airway control, blood pressure targets by stroke treatment type, management of cerebral edema, hemorrhagic conversion, fibrinolytic reversal, and complications prevention (e.g., DVT, infections, arrhythmias, hyperglycemia). No specific discussion of TXA or its role in inhibiting fibrinolysis in bleeding patients with low blood pressure.",
          "pmid": "36333037",
          "title": "Neurocritical Care Aspects of Ischemic Stroke Management.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies catheter-directed low-dose fibrinolysis with tPA for pulmonary embolism, not tranexamic acid (TXA). It evaluates enhancement of fibrinolysis, not inhibition, and does not address TXA, antifibrinolysis, or bleeding control in hypotensive/hemorrhagic patients. Thus it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Ultrasound-facilitated, catheter-directed, low-dose tPA fibrinolysis in massive/submassive PE reduced RV/LV ratio, pulmonary artery systolic pressure, and thrombus burden, with low rates of major bleeding and no intracranial hemorrhage. The study concerns promoting fibrinolysis for clot resolution in PE, not inhibiting fibrinolysis to control bleeding.",
          "pmid": "26315743",
          "title": "A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses mechanisms of blood pressure regulation and the pathophysiology of hypertension, focusing on renal, neural, endocrine, and local tissue systems. It does not mention tranexamic acid (TXA), fibrinolysis, or the relationship between antifibrinolytic therapy and bleeding or hypotension. Therefore, it neither supports nor contradicts the proposed mechanism of TXA acting via inhibition of fibrinolysis in patients with excessive bleeding and low blood pressure.",
          "key_findings": "Suboptimal blood pressure control is a major cardiovascular risk; blood pressure regulation involves cardiovascular, renal, neural, endocrine, and local tissue systems; kidneys and renal-pressure natriuresis play a central role in long-term blood pressure control; factors such as activation of renin-angiotensin-aldosterone and sympathetic systems, oxidative stress, endothelin, inflammatory cytokines, and reduced nitric oxide contribute to chronic hypertension.",
          "pmid": "23720252",
          "title": "Hypertension: physiology and pathophysiology.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on dietary salt intake, hypertension, and blood pressure regulation mechanisms. It does not mention tranexamic acid (TXA), fibrinolysis, antifibrinolytic therapy, or management of excessive bleeding or low blood pressure. Therefore, it neither supports nor contradicts the proposed mechanism of TXA acting via inhibition of fibrinolysis in bleeding patients.",
          "key_findings": "Excessive salt intake is associated with increased risk of hypertension and related cardiovascular and renal diseases; salt reduction lowers blood pressure, particularly in hypertensive and salt-sensitive individuals. Mechanisms discussed include volume expansion, renal sodium handling, RAAS alterations, sympathetic activation, and possible inflammation. No discussion of coagulation, fibrinolysis, TXA, or treatment of bleeding or hypotension.",
          "pmid": "27757935",
          "title": "Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses losartan\u2019s effects on TGF-beta signaling and corneal/ocular fibrosis. It does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or blood pressure, nor any coagulation-related mechanisms. Therefore it neither supports nor contradicts the proposed mechanism of TXA inhibiting fibrinolysis in bleeding patients.",
          "key_findings": "Topical losartan, an angiotensin II receptor blocker, inhibits TGF-beta signaling via ERK, reduces corneal scarring/fibrosis in animal models and case reports, and is proposed for various ocular fibrotic diseases and conditions where TGF-beta is involved.",
          "pmid": "36877777",
          "title": "Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses prevention and control of hypertension through lifestyle, environmental, and care-delivery strategies. It does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or low blood pressure, nor any pharmacologic mechanism related to coagulation or antifibrinolytic therapy. Therefore it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Focus on hypertension as a leading cardiovascular risk factor; roles of genetic, environmental, and social determinants; strategies for blood pressure control (lifestyle modification, team-based care, adherence, minimizing therapeutic inertia). No discussion of TXA, fibrinolysis, hemorrhage, or blood pressure in the context of excessive bleeding.",
          "pmid": "30190007",
          "title": "Prevention and Control of Hypertension: JACC Health Promotion Series.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses intradialytic hypotension, its hemodynamic pathophysiology, risk factors, and various non-TXA interventions. It does not mention tranexamic acid, fibrinolysis, or any coagulation/fibrinolytic mechanisms in relation to hypotension or bleeding, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "IDH is described as resulting from interactions between ultrafiltration rate, cardiac output, and arteriolar tone, with clinical implications and management strategies including dialysate cooling, ultrafiltration and sodium profiling, midodrine, mannitol, exercise, and pneumatic compression; no discussion of TXA, fibrinolysis, or antifibrinolytic therapy is present.",
          "pmid": "33391741",
          "title": "An update review of intradialytic hypotension: concept, risk factors, clinical implications and management.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses malignant hypertension, its pathogenesis, and management focused on blood pressure lowering, but it does not mention tranexamic acid (TXA), fibrinolysis, coagulation, or bleeding. Therefore, it neither supports nor contradicts the proposed mechanism of TXA inhibiting fibrinolysis in patients with excessive bleeding and low blood pressure.",
          "key_findings": "Malignant hypertension is described as a hypertensive emergency with severely elevated blood pressure, acute microvascular damage, and a need for rapid BP reduction. Causes include nonadherence to antihypertensive therapy and certain drugs (antiangiogenic and immunosuppressant agents). Management centers on blood pressure control; coagulation or antifibrinolytic therapy is not addressed.",
          "pmid": "38658108",
          "title": "Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses Korean Red Ginseng in the context of metabolic syndrome and related metabolic/cardiovascular conditions. It does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or blood pressure management in hemorrhagic contexts, nor any mechanism involving inhibition of fibrinolysis. Therefore it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Korean Red Ginseng is described as having anti-inflammatory, anti-fatigue, anti-obesity, antioxidant, and anti-cancer effects, and its use in treating metabolic conditions like obesity, cardiovascular disease, insulin resistance, diabetes, dyslipidemia, and non-alcoholic fatty liver disease is summarized. No data are presented regarding fibrinolysis, TXA, or treatment of excessive bleeding or hypotension.",
          "pmid": "34025131",
          "title": "Effect of Korean Red Ginseng on metabolic syndrome.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses autonomic dysreflexia, cardiovascular dysfunction, and renin-angiotensin system modulation after spinal cord injury, but does not mention tranexamic acid (TXA), fibrinolysis, or management of bleeding or hypotension. Therefore, it neither supports nor contradicts the proposed mechanism of TXA acting via inhibition of fibrinolysis in bleeding patients with low blood pressure.",
          "key_findings": "High-level spinal cord injury leads to autonomic dysreflexia characterized by hypertension and bradycardia; mechanisms involve loss of supraspinal control, maladaptive plasticity, and excessive sympathetic activity. The renin-angiotensin system is upregulated post-injury and may be involved in autonomic dysreflexia. Cell transplantation of embryonic presympathetic neurons can improve cardiovascular regulation, and combining this with renin-angiotensin system inhibition may further enhance cardiovascular recovery. No information is provided about TXA, fibrinolysis, or bleeding-related hypotension.",
          "pmid": "38084412",
          "title": "Autonomic Dysreflexia in Spinal Cord Injury: Mechanisms and Prospective Therapeutic Targets.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies corticosteroids (methylprednisolone) in persistent ARDS and their effects on mortality, ventilator-free days, shock-free days, oxygenation, and blood pressure. It does not involve tranexamic acid (TXA), fibrinolysis, or mechanisms of antifibrinolytic therapy in bleeding or hypotensive patients, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Methylprednisolone in persistent ARDS did not change 60- or 180-day overall mortality versus placebo, improved ventilator-free and shock-free days, oxygenation, compliance, and blood pressure with fewer vasopressor days, did not increase infectious complications, but increased neuromuscular weakness and was associated with higher mortality when started more than 14 days after ARDS onset.",
          "pmid": "16625008",
          "title": "Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses hyperkalemia, renal potassium and sodium handling, WNK signaling, and blood pressure regulation. It does not mention tranexamic acid (TXA), fibrinolysis, hemostasis, bleeding, or low blood pressure, nor any mechanism involving inhibition of fibrinolysis. Therefore it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "The article reviews how mutations leading to excessive activity of WNK kinases in the distal nephron affect renal Na+ and K+ handling, contributing to hyperkalemia and hypertension. It outlines WNK signaling as a key pathway in adaptation to systemic potassium changes and suggests pharmacologic targeting of WNKs to manage hypertension while preventing hyperkalemia.",
          "pmid": "31800077",
          "title": "Hyperkalemia and blood pressure regulation.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses causes and management of resistant hypertension, focusing on compliance, physician-related factors, volume status, sympathetic activation, lifestyle factors, and secondary hypertension. It does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or hypotension, nor any mechanism involving inhibition of fibrinolysis in bleeding patients.",
          "key_findings": "Resistant hypertension is attributed to inadequate compliance, physician-related errors, volume overload, sympathetic activation, concomitant medications, lifestyle factors (obesity, alcohol, smoking), and secondary hypertension; no discussion of TXA, fibrinolysis, or bleeding-related mechanisms.",
          "pmid": "16429642",
          "title": "Resistant hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses hypotensive components of snake venom and their mechanisms (e.g., ACE inhibition, bradykinin potentiation, natriuretic peptides, phospholipases A2), but it does not mention tranexamic acid (TXA), fibrinolysis, or any mechanism involving inhibition of fibrinolysis in the context of bleeding or low blood pressure. Therefore it neither supports nor conflicts with the proposed TXA mechanism.",
          "key_findings": "Snake venom components (bradykinin potentiating peptides, natriuretic peptides, phospholipases A2, serine proteases, VEGF, etc.) can lower blood pressure via mechanisms like ACE inhibition, enhanced bradykinin effects, arachidonic acid/prostaglandin generation, and mimicking endogenous vasoactive factors; the review focuses on antihypertensive mechanisms, not fibrinolysis inhibition or TXA.",
          "pmid": "31370142",
          "title": "Hypotensive Snake Venom Components-A Mini-Review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses anthrax pathophysiology and potential treatments focused on toxins, cardiomyocyte MAP kinase inhibition, and vessel cAMP stimulation to control terminal hypotension. It does not mention tranexamic acid (TXA), fibrinolysis, or any mechanism involving inhibition of fibrinolysis in the context of bleeding or low blood pressure. Therefore, it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Anthrax infection pathogenesis involves spore germination in macrophages and toxin effects on heart and blood vessels. Proposed therapeutic strategies include controlling germination via preventing macrophage paralysis and death, and controlling terminal hypotension by inhibiting cardiomyocyte MAP kinase and stimulating vascular cAMP.",
          "pmid": "19273366",
          "title": "Pathophysiology of anthrax.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses resistant hypertension, its causes, evaluation, and treatment (including aldosterone antagonists and carotid baroreceptor activation), but does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or hypotension. Therefore it neither supports nor contradicts the proposed mechanism of TXA acting via inhibition of fibrinolysis in bleeding patients with low blood pressure.",
          "key_findings": "Defines resistant hypertension; outlines need to rule out pseudoresistance and secondary causes; highlights roles of salt intake, comorbidities, and target organ damage; notes benefit of aldosterone antagonists as a fourth-line therapy; mentions investigational carotid baroreceptor activation. No discussion of TXA, fibrinolysis, or bleeding physiology.",
          "pmid": "18769797",
          "title": "[Resistant hypertension].",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses definitions, pathophysiology, and treatment approaches for refractory versus resistant hypertension, focusing on sympathetic activity, intravascular volume, aldosterone, and antihypertensive/device-based therapies. It does not mention tranexamic acid (TXA), fibrinolysis, bleeding, or blood pressure in the context of antifibrinolytic treatment, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Refractory hypertension is defined as uncontrolled blood pressure despite \u22655 antihypertensive agents and is primarily attributed to increased sympathetic activity. Resistant hypertension is mainly due to increased intravascular fluid volume, often from hyperaldosteronism and excess sodium intake. Patients with refractory hypertension have more target organ damage and do not have elevated aldosterone levels. Device-based therapies are being evaluated. No discussion of TXA, fibrinolysis, or bleeding-related hypotension is provided.",
          "pmid": "35384577",
          "title": "An Update on Refractory Hypertension.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "isbp",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Previous studies suggest that early administration of TXA significantly reduces mortality in patients with trauma-induced coagulopathy, especially under hypoperfusion states.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"systolic blood pressure\" OR \"blood pressure\" OR \"initial blood pressure\" OR hypotension) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"administration\" OR \"significantly\" OR \"hypoperfusion\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "medium",
          "reasoning": "The abstract provides strong evidence that early administration of TXA (within 3 hours) reduces mortality in bleeding trauma patients, but it does not specifically analyze or stratify outcomes by the presence of trauma-induced coagulopathy or by hypoperfusion status. It even notes no variation in effect by systolic blood pressure, which is a proxy for shock/hypoperfusion, and does not show an enhanced effect specifically under hypoperfusion. Therefore, while it supports early TXA in general trauma populations, it does not directly support the more specific mechanism that TXA particularly reduces mortality in trauma-induced coagulopathy under hypoperfusion states.",
          "key_findings": "1) In 20,211 adult trauma patients within 8 hours of injury, TXA reduced all-cause 28\u2011day mortality (RR 0.91, 95% CI 0.85\u20130.97). 2) TXA reduced death due to bleeding (RR 0.85, 95% CI 0.76\u20130.96). 3) Strong time\u2011dependent effect: treatment \u22641 hour (RR 0.68) and 1\u20133 hours (RR 0.79) reduced death due to bleeding, whereas treatment >3 hours increased it (RR 1.44). 4) The authors found no evidence that TXA\u2019s effect on death due to bleeding varied by systolic blood pressure, Glasgow Coma Scale score, or type of injury, and they did not specifically assess trauma\u2011induced coagulopathy or hypoperfusion subgroups.",
          "pmid": "23477634",
          "title": "The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses diagnosis, subtypes, and management of orthostatic hypotension and does not mention trauma, coagulopathy, hypoperfusion states, tranexamic acid (TXA), or mortality effects of TXA. It therefore neither supports nor contradicts the proposed mechanism about early TXA use in trauma-induced coagulopathy.",
          "key_findings": "Describes clinical features, subtypes, diagnostic approach, and primarily non-pharmacologic management strategies for orthostatic hypotension, including lifestyle measures and discontinuation of blood pressure\u2013lowering drugs; no discussion of TXA, trauma, or coagulopathy.",
          "pmid": "35841911",
          "title": "Diagnosis and treatment of orthostatic hypotension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses pathophysiology, diagnosis, and management of traumatic spinal cord injury, including hemodynamic monitoring, early surgical decompression, blood pressure augmentation, and possible methylprednisolone. It does not mention tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states, or mortality outcomes related to TXA use, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Key management strategies described include intensive care hemodynamic monitoring, early surgical decompression, blood pressure augmentation, and potential methylprednisolone use after traumatic spinal cord injury; no data or statements are provided regarding TXA or its effect on mortality in trauma-induced coagulopathy or hypoperfusion.",
          "pmid": "28447605",
          "title": "Traumatic spinal cord injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates intensive versus standard blood-pressure lowering with intravenous nicardipine in acute intracerebral hemorrhage and reports outcomes on death, disability, and renal adverse events. It does not involve tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states, or mortality effects of antifibrinolytic therapy. Therefore, it neither supports nor contradicts the proposed mechanism regarding early TXA administration in trauma.",
          "key_findings": "In 1000 patients with intracerebral hemorrhage treated with intravenous nicardipine, targeting systolic blood pressure 110\u2013139 mm Hg versus 140\u2013179 mm Hg showed no difference in death or disability at 3 months (38.7% vs 37.7%; RR 1.04, 95% CI 0.85\u20131.27). Intensive treatment increased renal adverse events (9.0% vs 4.0%; P=0.002). No data on TXA, trauma-induced coagulopathy, or hypoperfusion were provided.",
          "pmid": "27276234",
          "title": "Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses stroke diagnosis, reperfusion therapies, and investigational haemostatic/surgical approaches for intracerebral haemorrhage, but does not mention tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states in trauma, or mortality effects of early TXA administration. Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "The abstract notes that stroke management includes intravenous thrombolysis and endovascular thrombectomy for ischaemic stroke, with haemostatic agents and surgery being investigational for intracerebral haemorrhage; it does not specify TXA or address trauma-induced coagulopathy.",
          "pmid": "32653056",
          "title": "Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies zilebesiran, an RNAi therapeutic targeting angiotensinogen for hypertension management. It does not involve trauma, TXA (tranexamic acid), trauma-induced coagulopathy, hypoperfusion states, or mortality outcomes. Therefore it provides no evidence for or against the proposed TXA-related mechanism.",
          "key_findings": "Zilebesiran reduced serum angiotensinogen levels in a dose-dependent manner and produced sustained reductions in ambulatory blood pressure for up to 24 weeks, with mainly mild injection-site reactions and no significant safety concerns such as hypotension or hyperkalemia reported. These results are unrelated to TXA or trauma-induced coagulopathy.",
          "pmid": "37467498",
          "title": "Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies timing of antihypertensive medication and its effect on cardiovascular events in ambulatory hypertensive adults. It does not involve trauma, tranexamic acid (TXA), coagulopathy, hypoperfusion, or mortality from trauma-induced coagulopathy, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "In a randomized trial of 3357 adults with hypertension, bedtime versus morning administration of once-daily antihypertensive medications resulted in no significant difference in the rate of all-cause death or hospitalization/ED visits for major cardiovascular events (adjusted HR 0.96, 95% CI 0.77\u20131.19), and safety outcomes were similar between groups.",
          "pmid": "40354045",
          "title": "Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns early administration of tranexamic acid (TXA) and its impact on mortality in trauma-induced coagulopathy, especially under hypoperfusion. The abstract instead evaluates early administration of 4-factor prothrombin complex concentrate (4F-PCC) and its effects on blood product consumption and thromboembolic events. It does not study TXA, mortality outcomes related to TXA, or trauma-induced coagulopathy mechanisms specific to TXA, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "In a randomized, double-blind trial of 324 trauma patients at risk of massive transfusion, early administration of 4F-PCC compared with placebo did not reduce 24-hour blood product consumption (median 12 U vs 11 U; P = .72) and was associated with more thromboembolic events (35% vs 24%; RR 1.48, P = .03). TXA was not investigated.",
          "pmid": "36942533",
          "title": "Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses management of orthostatic hypotension and supine hypertension in Parkinson's disease, focusing on autonomic dysfunction, blood pressure monitoring, and use of sympathomimetic agents and fludrocortisone. It does not mention tranexamic acid (TXA), trauma, coagulopathy, hypoperfusion, or mortality outcomes, and therefore provides no evidence for or against the proposed mechanism regarding early TXA administration in trauma-induced coagulopathy.",
          "key_findings": "Orthostatic hypotension is common in Parkinson's disease; diagnosis is via supine and standing blood pressure measurements; treatment centers on correcting non-neurogenic causes, lifestyle and non-pharmacological measures, and when needed sympathomimetic agents or fludrocortisone; about half of patients with neurogenic orthostatic hypotension have concomitant supine or nocturnal hypertension; timely management improves quality of life and reduces complications. No discussion of TXA, trauma, or coagulopathy is present.",
          "pmid": "32716319",
          "title": "Management of Orthostatic Hypotension in Parkinson's Disease.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses orthostatic hypotension, hypertension, autonomic dysfunction, and management strategies such as short-acting vasoactive agents, but it does not mention trauma, coagulopathy, hypoperfusion in the trauma setting, or the use or timing of tranexamic acid (TXA). Therefore, it neither supports nor conflicts with the proposed mechanism about early TXA administration reducing mortality in trauma-induced coagulopathy under hypoperfusion.",
          "key_findings": "Orthostatic hypotension is described as a common comorbidity of hypertension, related to autonomic dysfunction and complex blood pressure regulation. Management focuses on characterizing patterns and triggers, removing aggravating factors, optimizing antihypertensive regimens, and using measures such as counter-maneuvers and short-acting vasoactive agents (midodrine, droxidopa). The statement emphasizes that intensive blood pressure treatment generally does not cause OH, though some antihypertensives may unmask it in patients with autonomic impairment. No discussion of TXA, trauma-induced coagulopathy, or trauma-related hypoperfusion is provided.",
          "pmid": "38205630",
          "title": "Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses pathophysiology and management of traumatic shock, focusing on vasopressor use, hypotensive resuscitation, and balancing intravascular volume and vascular tone. It does not mention tranexamic acid (TXA), trauma-induced coagulopathy, or any data on mortality effects of early TXA administration, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "The article argues that: (1) vasopressor use in severely injured trauma patients is controversial but may be useful in certain contexts; (2) hypotensive resuscitation has limited and inconsistent supporting data and may be counterintuitive given goals of shock resuscitation; (3) resuscitation should aim to restore intravascular volume, correct coagulopathy, and maintain organ perfusion; (4) persistent hypotension/hypoperfusion worsen coagulopathy and organ function. No information is provided about TXA timing, its effects on mortality, or its role in trauma-induced coagulopathy.",
          "pmid": "33908898",
          "title": "Vasopressors in Trauma: A Never Event?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract is a broad review of recent advances in spontaneous intracerebral hemorrhage and mentions hemostatic therapies in general but does not specifically discuss tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states, or mortality effects related to early TXA administration.",
          "key_findings": "The review covers topics such as risk factors, imaging predictors and scoring for hematoma expansion, hemostatic therapies, acute blood pressure lowering, intraventricular alteplase, and surgical therapies in spontaneous intracerebral hemorrhage, without specific data on TXA or trauma-related coagulopathy.",
          "pmid": "30906532",
          "title": "Recent advances in spontaneous intracerebral hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates prehospital blood-pressure reduction in hyperacute stroke and its impact on functional outcomes; it does not involve tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states, or mortality effects of TXA. Therefore it neither supports nor contradicts the proposed TXA-related mechanism.",
          "key_findings": "In a randomized trial of 2404 suspected acute stroke patients, intensive prehospital blood-pressure lowering versus usual care showed no overall difference in 90-day functional outcome or serious adverse events. Subgroup analyses suggested benefit in hemorrhagic stroke and harm in ischemic stroke, but no data on TXA, trauma, coagulopathy, or mortality reduction by TXA were presented.",
          "pmid": "38752650",
          "title": "Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses the pathophysiology of acute traumatic coagulopathy, hypoperfusion, and hyperfibrinolysis, and mentions correction of hyperfibrinolysis as part of damage control resuscitation, but it does not mention tranexamic acid (TXA), its timing, or any mortality outcomes associated with early TXA administration. Therefore it neither supports nor contradicts the specific proposed mechanism about early TXA reducing mortality under hypoperfusion states.",
          "key_findings": "The abstract describes mechanisms of acute traumatic coagulopathy (activation of protein C, endothelial glycocalyx disruption, fibrinogen depletion, platelet dysfunction, hypothermia, acidaemia, hyperfibrinolysis) and emphasizes early identification for massive transfusion and use of damage control resuscitation, including correction of hyperfibrinolysis. It does not reference TXA or provide data on the effect of early TXA administration on mortality.",
          "pmid": "27940454",
          "title": "Acute traumatic coagulopathy: pathophysiology and resuscitation.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates fostamatinib, a Syk inhibitor, for immune thrombocytopenia and does not involve trauma, trauma-induced coagulopathy, hypoperfusion, or tranexamic acid (TXA). It provides no data about timing or mortality effects of TXA and therefore neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Fostamatinib produced higher stable platelet response rates (18% vs 2%) and overall response rates (43% vs 14%) compared with placebo in adults with persistent/chronic ITP, with manageable adverse events; these results pertain to Syk inhibition in ITP, not TXA use in trauma-induced coagulopathy.",
          "pmid": "29696684",
          "title": "Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies catheter-directed, low-dose tPA fibrinolysis for acute massive and submassive pulmonary embolism, assessing RV/LV ratio, pulmonary pressures, thrombus burden, and bleeding. The proposed mechanism concerns early administration of tranexamic acid (TXA) in trauma-induced coagulopathy under hypoperfusion. This trial does not involve trauma, coagulopathy management with antifibrinolytics, TXA use, timing of TXA, or mortality outcomes in trauma patients, so it neither supports nor contradicts the specific TXA-related mechanism.",
          "key_findings": "Ultrasound-facilitated, catheter-directed low-dose tPA in 150 PE patients reduced RV/LV diameter ratio (1.55 to 1.13), pulmonary artery systolic pressure (51.4 to 36.9 mm Hg), and modified Miller Index, with 1 severe and 16 moderate bleeding events and no intracranial hemorrhage. No data on TXA, trauma-induced coagulopathy, hypoperfusion in trauma, or trauma mortality.",
          "pmid": "26315743",
          "title": "A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses prehospital damage control resuscitation, bleeding control, fluid management, permissive hypotension, and hypothermia prevention but does not mention tranexamic acid (TXA), trauma-induced coagulopathy, or mortality effects of early TXA administration. Therefore it neither supports nor contradicts the proposed TXA-specific mechanism.",
          "key_findings": "Recommends prehospital hemostatic techniques (tourniquets), low-volume crystalloid resuscitation with permissive hypotension, and hypothermia management using warmed blankets and warmed IV fluids, emphasizing that these measures should not delay transport. No data or statements regarding TXA use, timing, coagulopathy, or mortality outcomes are provided.",
          "pmid": "33795898",
          "title": "Prehospital Damage Control: The Management of Volume, Temperature\u2026 and Bleeding!",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns early administration of tranexamic acid (TXA) reducing mortality in trauma-induced coagulopathy, particularly under hypoperfusion. The abstract instead evaluates low-dose arginine vasopressin (AVP) supplementation in hemorrhagic shock and its impact on blood product use, complications, and mortality. It does not involve TXA, coagulopathy-specific endpoints, or timing of antifibrinolytic therapy, so it neither supports nor contradicts the TXA-related mechanism.",
          "key_findings": "In a randomized, double-blind, placebo-controlled trial of 100 adult trauma patients with hemorrhagic shock, low-dose AVP (bolus then infusion \u22640.04 U/min for 48 hours) reduced blood product requirements at 48 hours (median 1.4 L vs 2.9 L; P = .01) without significant differences in crystalloid use, vasopressor requirements, or 30-day mortality (12% in both groups). The AVP group had lower rates of deep venous thrombosis (11% vs 34%; P = .02). No TXA use or effects on trauma-induced coagulopathy were studied.",
          "pmid": "31461138",
          "title": "Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract investigates the timing and effects of intensive blood pressure lowering in acute intracerebral haemorrhage, not the use or timing of tranexamic acid (TXA) in trauma-induced coagulopathy or hypoperfusion states. Although both involve acute hemorrhagic conditions and early intervention, the study does not examine TXA, coagulopathy correction, or trauma-related hypoperfusion, so it neither supports nor contradicts the proposed TXA mechanism.",
          "key_findings": "Early intensive blood pressure lowering (target systolic BP <140 mm Hg within 1 hour) in intracerebral haemorrhage patients improved functional outcomes, reduced neurological deterioration, death, and serious adverse events, with greatest benefit when initiated within 3 hours of symptom onset; no clear effect on haematoma growth was observed. No mention is made of TXA, trauma-induced coagulopathy, or hypoperfusion.",
          "pmid": "40541207",
          "title": "Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates the effect of intensive antihypertensive treatment on orthostatic hypertension in adults with elevated blood pressure. It does not involve trauma patients, tranexamic acid (TXA), trauma-induced coagulopathy, hypoperfusion states, or mortality outcomes. Therefore it neither supports nor contradicts the proposed TXA-related mechanism.",
          "key_findings": "In a pooled analysis of nine randomized trials (31,124 participants), intensive blood pressure treatment modestly reduced the occurrence of orthostatic hypertension compared with less intensive treatment (odds ratio 0.93, 95% CI 0.90\u20130.96), with some variation by race and diabetes status, but no data on TXA, trauma, coagulopathy, hypoperfusion, or mortality.",
          "pmid": "40132860",
          "title": "Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ninjurytime",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Acute trauma can lead to rapid-onset fibrinolysis, where early TXA administration attenuates this response, thus diminishing the risk of excessive bleeding.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"time to treatment\" OR \"treatment delay\" OR \"injury time\" OR \"time from injury\") AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"administration\" OR \"fibrinolysis\" OR \"diminishing\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 3,
      "conflict_count": 0,
      "neutral_count": 17,
      "support_percentage": 15.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.15,
      "abstracts_analyzed": [
        {
          "stance": "support",
          "confidence": "high",
          "reasoning": "The abstract shows that early administration of tranexamic acid (an antifibrinolytic) in acutely injured, bleeding trauma patients significantly reduces death due to bleeding when given within 3 hours of injury, with the greatest benefit when given within 1 hour. This aligns with the proposed mechanism that acute trauma induces rapid-onset fibrinolysis, and that early TXA attenuates this response and thereby diminishes the risk of excessive bleeding. Although fibrinolysis itself is not directly measured, the time-dependent mortality benefit from early TXA in acute trauma is consistent with that specific biological mechanism.",
          "key_findings": "1) In 20,211 adult trauma patients with or at risk of significant bleeding, early TXA (1 g bolus then 1 g over 8 hours, within 8 hours of injury) reduced all-cause mortality at 28 days (RR 0.91; 95% CI 0.85\u20130.97; p=0.0035). 2) Death due to bleeding was reduced overall with TXA (4.9% vs 5.7%; RR 0.85; 95% CI 0.76\u20130.96; p=0.0077). 3) There was strong evidence of a time-to-treatment interaction (p<0.0001): treatment \u22641 hour from injury reduced death due to bleeding (RR 0.68; 95% CI 0.57\u20130.82), treatment 1\u20133 hours also reduced death due to bleeding (RR 0.79; 95% CI 0.64\u20130.97), whereas treatment >3 hours increased death due to bleeding (RR 1.44; 95% CI 1.12\u20131.84). 4) Authors conclude that early TXA safely reduces risk of death in bleeding trauma patients and that treatment beyond 3 hours is unlikely to be effective.",
          "pmid": "23477634",
          "title": "The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates tenecteplase, a thrombolytic (fibrinolytic) drug, for ischemic stroke treatment and reports outcomes and hemorrhage risk. The proposed mechanism concerns trauma-induced rapid-onset fibrinolysis and modulation of that response by early tranexamic acid (an antifibrinolytic) to reduce bleeding. This study neither involves trauma patients nor examines endogenous trauma-related fibrinolysis or the effects of TXA, so it does not provide direct evidence for or against the proposed mechanism.",
          "key_findings": "In patients with ischemic stroke treated 4.5\u201324 hours after last-known-well, tenecteplase improved 90-day functional outcome compared with standard medical therapy but was associated with higher symptomatic intracranial hemorrhage risk; mortality was similar between groups. No data relate to acute trauma, trauma-induced fibrinolysis, or tranexamic acid use.",
          "pmid": "38884324",
          "title": "Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The mechanism proposes that acute trauma can trigger rapid fibrinolysis and that early tranexamic acid (TXA) administration attenuates this, reducing excessive bleeding risk. The trial shows that TXA given within 3 hours after traumatic brain injury reduces head injury\u2013related death, particularly in mild-to-moderate TBI, and that earlier treatment is more effective than later treatment. This time-dependent mortality benefit with an antifibrinolytic agent after acute trauma is consistent with (though not direct proof of) early trauma-associated fibrinolysis that can be mitigated by TXA. The study does not directly measure fibrinolysis or bleeding parameters but its findings align with the proposed early TXA effect on trauma-related bleeding risk.",
          "key_findings": "1) In patients treated within 3 hours of TBI, head injury\u2013related death was 18.5% with TXA vs 19.8% with placebo (RR 0.94, 95% CI 0.86\u20131.02), with a stronger effect after excluding those moribund at baseline (RR 0.89, 95% CI 0.80\u20131.00). 2) TXA reduced head injury\u2013related death in mild-to-moderate TBI (RR 0.78, 95% CI 0.64\u20130.95) but not in severe TBI (RR 0.99, 95% CI 0.91\u20131.07), with evidence of heterogeneity. 3) Early treatment was more effective than later treatment in mild/moderate TBI (p=0.005). 4) There was no increase in vascular occlusive events (RR 0.98, 95% CI 0.74\u20131.28) or seizures (RR 1.09, 95% CI 0.90\u20131.33), indicating TXA\u2019s safety in this context.",
          "pmid": "31623894",
          "title": "Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses schizophrenia\u2019s etiology, pathophysiology, clinical expression, and treatment in psychiatry, without any mention of acute trauma, fibrinolysis, bleeding, or tranexamic acid (TXA). It neither supports nor contradicts the proposed trauma-related fibrinolysis mechanism.",
          "key_findings": "Focuses on schizophrenia as a heritable, heterogeneous psychiatric syndrome; outlines genetic and environmental risk factors (e.g., urban residence, cannabis use, childhood trauma), brain alterations, and antipsychotic/psychosocial treatments. No data on coagulation, fibrinolysis, trauma physiology, or TXA administration.",
          "pmid": "38086109",
          "title": "The schizophrenia syndrome, circa 2024: What we know and how that informs its nature.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The trial evaluates early tranexamic acid in traumatic brain injury for functional neurologic and clinical outcomes but does not measure fibrinolysis, hyperfibrinolytic states, or TXA\u2019s effect on fibrinolytic activity. The lack of improvement in outcomes with early TXA does not by itself confirm or refute the specific mechanistic claim that acute trauma causes rapid-onset fibrinolysis that TXA attenuates.",
          "key_findings": "In patients with moderate/severe TBI treated within 2 hours of injury, out-of-hospital tranexamic acid (various dosing regimens) vs placebo showed no statistically significant difference in 6\u2011month favorable neurologic outcome (65% vs 62%), 28\u2011day mortality (14% vs 17%), Disability Rating Scale score, progression of intracranial hemorrhage (16% vs 20%), seizures, or thromboembolic events. No fibrinolytic biomarkers or direct measures of fibrinolysis were reported.",
          "pmid": "32897344",
          "title": "Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies prehospital blood-pressure reduction in hyperacute stroke and its impact on functional outcomes and serious adverse events. It does not address trauma, fibrinolysis, or the use of tranexamic acid (TXA), nor any mechanism involving TXA attenuation of trauma-induced fibrinolysis.",
          "key_findings": "In patients with suspected acute stroke and elevated systolic blood pressure treated in the ambulance, early intensive blood-pressure lowering did not improve overall functional outcome at 90 days compared with usual care. Subgroup analysis showed improved outcomes in hemorrhagic stroke and worse outcomes in ischemic stroke with prehospital BP reduction. No data are presented on trauma, fibrinolysis, or TXA.",
          "pmid": "38752650",
          "title": "Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns complications of vasopressor infusion via peripheral venous catheters and does not discuss trauma-induced fibrinolysis, tranexamic acid (TXA), bleeding risk, or coagulation/fibrinolytic pathways. Therefore it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Systematic review and meta-analysis of 9 studies (1835 patients) found a low prevalence (about 8.6%) of mostly minor complications from vasopressor infusion through peripheral IVs, with studies using safety guidelines showing significantly fewer complications. No data on trauma, TXA, or fibrinolysis are presented.",
          "pmid": "33039229",
          "title": "Complication of vasopressor infusion through peripheral venous catheter: A systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "high",
          "reasoning": "The abstract shows that earlier TXA administration after acute trauma (within ~90 minutes) reduces 28\u2011day mortality, with diminishing benefit as time from injury increases. This is consistent with a rapid-onset, early post-trauma fibrinolytic process that can be attenuated by early TXA, thereby reducing lethal bleeding risk. While fibrinolysis is not directly measured, the time-dependent mortality benefit of TXA aligns with the proposed mechanism of an early, transient, TXA-responsive fibrinolytic phase.",
          "key_findings": "1) In an exploratory analysis of the PATCH-Trauma trial (1,287 major trauma patients with suspected trauma-induced coagulopathy), median time to first dose was 79 minutes. 2) Risk of death within 28 days increased as time from injury to first TXA/placebo dose increased, with benefit of TXA most pronounced up to 90 minutes. 3) TXA within 90 minutes: 17% mortality (67/393) vs 25% (91/363) with placebo; adjusted risk ratio 0.64 (95% CI 0.50\u20130.82), indicating a significant mortality reduction. 4) TXA beyond 90 minutes: no mortality reduction; adjusted risk ratio 1.04 (95% CI 0.74\u20131.47). 5) Authors conclude the optimal therapeutic window for TXA after trauma may be within 90 minutes, demonstrating a clear time\u2011critical effect of TXA consistent with blocking early post-trauma fibrinolytic activity.",
          "pmid": "40751727",
          "title": "Tranexamic Acid Timing and Mortality Impact After Trauma.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines the efficacy and safety of a capsaicin 8% patch for painful diabetic peripheral neuropathy and does not involve acute trauma, fibrinolysis, bleeding risk, or tranexamic acid (TXA). Therefore, it neither supports nor contradicts the proposed mechanism about trauma-induced fibrinolysis and TXA\u2019s effects.",
          "key_findings": "A single 30-minute application of capsaicin 8% patch in patients with painful diabetic peripheral neuropathy produced modest but statistically significant reductions in pain and improvements in sleep versus placebo over 12 weeks, with similar adverse event rates aside from application site reactions and no deterioration in sensory perception.",
          "pmid": "27746370",
          "title": "Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies optimal timing of starting direct oral anticoagulants after ischemic stroke due to atrial fibrillation. It does not involve acute trauma, fibrinolysis, tranexamic acid (TXA), or mechanisms of trauma-related bleeding control. Therefore it neither supports nor contradicts the proposed mechanism about trauma-induced fibrinolysis attenuated by early TXA.",
          "key_findings": "Earlier initiation of direct oral anticoagulants (day 3\u20134 vs days 6, 10, or 14 after AF-related ischemic stroke) tended to be favored, with low rates of both ischemic and hemorrhagic events and no clearly superior single start day identified. These results pertain to stroke anticoagulation timing, not trauma-induced fibrinolysis or TXA use.",
          "pmid": "40163159",
          "title": "Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses thrombolytic therapy (rt-PA and other agents) for acute ischemic stroke and its timing, efficacy, and bleeding risks. The proposed mechanism concerns trauma-induced rapid fibrinolysis and attenuation of this process by early tranexamic acid (TXA), an antifibrinolytic. This abstract focuses on pharmacologic induction of fibrinolysis (thrombolysis) in non-traumatic stroke and does not address trauma, endogenous rapid-onset fibrinolysis after injury, or the effects of TXA. Therefore it neither supports nor contradicts the specific trauma/TXA mechanism.",
          "key_findings": "Thrombolytic therapy (mainly rt-PA) within up to 6 hours of ischemic stroke reduces death or dependency but increases symptomatic intracranial hemorrhage and early deaths; treatment within 3 hours yields greater functional benefit without increasing mortality. These findings relate to deliberate pharmacologic thrombolysis in stroke, not to trauma-induced fibrinolysis or TXA use.",
          "pmid": "25072528",
          "title": "Thrombolysis for acute ischaemic stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates timing and efficacy of dual antiplatelet therapy (clopidogrel plus aspirin) after mild ischemic stroke or TIA and its effect on new stroke and bleeding risk over 90 days. It does not investigate trauma-induced rapid-onset fibrinolysis, the role of TXA, or mechanisms of acute traumatic bleeding control. Therefore, it neither supports nor contradicts the proposed mechanism about TXA-mediated attenuation of trauma-related fibrinolysis.",
          "key_findings": "Dual antiplatelet therapy initiated within 72 hours after mild ischemic stroke or TIA reduces risk of new stroke compared with aspirin alone, with a similar relative increase in moderate-to-severe bleeding across different initiation time windows (\u226424 h, >24\u201348 h, >48\u201372 h). No data on trauma, fibrinolysis, or tranexamic acid are presented.",
          "pmid": "39240565",
          "title": "Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of the INSPIRES Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates alteplase vs aspirin in minor nondisabling acute ischemic stroke and reports functional outcomes and intracranial hemorrhage risk. It does not involve trauma, acute trauma-induced fibrinolysis, or the use of tranexamic acid (TXA), nor does it assess modulation of fibrinolysis after trauma. Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "In patients with minor nondisabling acute ischemic stroke treated within 3 hours, alteplase did not improve favorable functional outcome at 90 days compared with aspirin (78.2% vs 81.5%), but was associated with symptomatic intracranial hemorrhage in 3.2% vs 0% with aspirin. No data on trauma, fibrinolysis, or TXA are presented.",
          "pmid": "29998337",
          "title": "Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies an early resuscitation protocol for sepsis involving fluids, vasopressors, and blood transfusion, and its effect on in-hospital mortality. It does not involve trauma patients, fibrinolysis, tranexamic acid (TXA), or any assessment of coagulation or bleeding outcomes, so it neither supports nor contradicts the proposed mechanism about trauma-induced fibrinolysis and early TXA administration.",
          "key_findings": "In Zambian adults with sepsis and hypotension, an early resuscitation protocol using IV fluids, vasopressors, and blood transfusion increased in-hospital mortality (48.1% vs 33.0% with usual care; RR 1.46, 95% CI 1.04\u20132.05). The protocol group received more IV fluids and more vasopressors. No data on trauma, fibrinolysis, TXA, or bleeding risk were reported.",
          "pmid": "28973227",
          "title": "Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses organizational and systems-level changes in trauma care (trauma teams, training, imaging, endovascular techniques) and their impact on patient outcomes. It does not mention fibrinolysis, tranexamic acid (TXA), biochemical responses to acute trauma, or timing of antifibrinolytic therapy, so it neither supports nor contradicts the proposed biological mechanism.",
          "key_findings": "Introduction of trauma teams, improved training (ATLS, simulation, video review), and advances in radiology and endovascular treatment have improved trauma patient outcomes and may influence future management and team composition.",
          "pmid": "24980423",
          "title": "Trauma team.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns timing of direct oral anticoagulant initiation after ischemic stroke in patients with atrial fibrillation and stratifies outcomes by infarct size. It does not involve acute trauma, fibrinolysis, tranexamic acid (TXA), or mechanisms of trauma\u2011induced coagulopathy or bleeding control. Therefore it neither supports nor contradicts the proposed mechanism about TXA attenuating rapid\u2011onset fibrinolysis after acute trauma.",
          "key_findings": "Early vs late DOAC initiation after ischemic stroke showed similar safety and efficacy across infarct sizes (minor, moderate, major), with no significant treatment interaction and no increase in symptomatic intracranial hemorrhage or other adverse events with early treatment. These findings relate to anticoagulation timing in stroke, not to TXA use, fibrinolysis, or trauma-related bleeding mechanisms.",
          "pmid": "38805207",
          "title": "Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses enzymatic wound debridement in chronic and burn wounds, comparing collagenase and papain-urea ointments to other debridement methods. It does not address acute trauma, fibrinolysis, tranexamic acid (TXA), or any mechanism involving modulation of fibrinolysis or bleeding risk.",
          "key_findings": "Collagenase ointment is more effective than placebo for debridement of necrotic tissue in pressure ulcers, leg ulcers, and partial-thickness burns; papain-urea may remove necrotic material more rapidly than collagenase but with similar healing progress; enzymatic debridement is a viable alternative when surgical or sharp debridement is not feasible, especially in patients with bleeding disorders. None of these findings relate to TXA or trauma-induced rapid-onset fibrinolysis.",
          "pmid": "18496083",
          "title": "Enzymatic wound debridement.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses early management of chronic myeloid leukaemia with tyrosine kinase inhibitors and factors influencing drug selection. It does not mention acute trauma, fibrinolysis, bleeding risk, or tranexamic acid (TXA), and therefore provides no evidence for or against the proposed mechanism.",
          "key_findings": "Early CML management focuses on selecting optimal BCR-ABL1\u2013targeted tyrosine kinase inhibitors based on disease biology, comorbidities, and goals such as deep molecular response and treatment-free remission.",
          "pmid": "31701368",
          "title": "Early Management of CML.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on infertility and fertility preservation in female cancer survivors, including effects of chemotherapy, radiation, and surgical treatments on reproductive function. It does not address trauma, fibrinolysis, bleeding risk, or the use of tranexamic acid (TXA), so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Cancer-directed therapies (high-dose alkylating agents, pelvic and brain radiation, surgical resection) reduce fertility in reproductive-age women; fertility preservation options include embryo/oocyte cryopreservation, ovarian tissue freezing, and GnRH analogues, with mixed evidence. No discussion of coagulation, fibrinolysis, trauma, or TXA.",
          "pmid": "25649243",
          "title": "Infertility in reproductive-age female cancer survivors.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns endovascular treatment versus general medical treatment (including rt-PA) for acute ischemic stroke. It evaluates functional outcomes, mortality, and intracerebral hemorrhage risk after these reperfusion strategies. It does not discuss trauma, acute trauma-induced fibrinolysis, tranexamic acid (TXA), or modulation of fibrinolysis as a mechanism to reduce bleeding. Therefore it neither supports nor contradicts the proposed trauma-related fibrinolysis mechanism.",
          "key_findings": "Endovascular treatment for acute ischemic stroke, compared with general treatment (including IV rt-PA), improved functional outcome, reduced all-cause mortality, but increased asymptomatic intracerebral hemorrhage at 90 days; beneficial subgroups included age <70, NIHSS \u226520, and treatment delay >5 hours.",
          "pmid": "32443338",
          "title": "Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ninjurytime",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Studies suggest that the hemostatic effect of TXA diminishes as time from injury increases; hence, quicker intervention aligns with pharmacodynamic principles.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"time to treatment\" OR \"treatment delay\" OR \"injury time\" OR \"time from injury\") AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"pharmacodynamic\" OR \"intervention\" OR \"principles\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses timing and strategy of coronary revascularization in cardiogenic shock after myocardial infarction, not the hemostatic or pharmacodynamic effects of tranexamic acid (TXA) or the time dependence of its hemostatic efficacy after injury. There is no mention of TXA, antifibrinolytics, or coagulation mechanisms, so it neither supports nor contradicts the proposed TXA-related mechanism.",
          "key_findings": "Immediate revascularization of the infarct-related coronary artery is supported as primary therapy for cardiogenic shock after acute myocardial infarction; the CULPRIT-SHOCK trial showed better outcomes with culprit-lesion-only PCI versus multivessel PCI. No data on TXA, hemostasis, or time-dependent pharmacodynamic effects of antifibrinolytic therapy are presented.",
          "pmid": "34751704",
          "title": "Cardiogenic Shock After Acute Myocardial Infarction: A Review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on the nature, etiology, pathophysiology, and treatment of schizophrenia, and briefly notes that early intervention improves outcomes. It does not discuss tranexamic acid (TXA), hemostasis, trauma, time-from-injury effects, or any pharmacodynamic principles related to TXA or bleeding control. Therefore, it neither supports nor contradicts the proposed mechanism about the time-dependent hemostatic effect of TXA after injury.",
          "key_findings": "The only timing-related statement is that early intervention in schizophrenia can reduce treatment delay and improve outcomes, which is unrelated to TXA, hemostasis, injury, or trauma care.",
          "pmid": "38086109",
          "title": "The schizophrenia syndrome, circa 2024: What we know and how that informs its nature.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses stress fractures of the foot and ankle, their epidemiology, risk factors, diagnosis, and management. It does not mention tranexamic acid (TXA), hemostasis, timing of pharmacologic intervention after injury, or any time-dependent hemostatic effect. Therefore it neither supports nor contradicts the proposed mechanism regarding TXA\u2019s diminishing hemostatic effect over time from injury.",
          "key_findings": "Stress fractures result from repeated submaximal stresses leading to microscopic bone injuries that can progress to frank fracture; diagnosis is often missed and delayed, which can cause prolonged pain, disability, risk of non-union, and possibly require operative treatment.",
          "pmid": "26412591",
          "title": "Stress fractures of the foot and ankle.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates very early blood-pressure reduction in suspected acute stroke in the prehospital setting. It does not involve tranexamic acid (TXA), hemostasis, or any time-dependent pharmacodynamic effect of an antifibrinolytic. Therefore, it neither supports nor contradicts the proposed mechanism about TXA\u2019s diminishing hemostatic effect with increasing time from injury.",
          "key_findings": "Prehospital blood-pressure reduction within approximately 1 hour of stroke onset did not improve overall functional outcomes at 90 days in undifferentiated acute stroke; it was associated with better outcomes in hemorrhagic stroke and worse outcomes in ischemic stroke. No mention of TXA, coagulation, or time-to-antifibrinolytic treatment effects.",
          "pmid": "38752650",
          "title": "Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates PCI strategies in cardiogenic shock complicating acute myocardial infarction, focusing on culprit-only versus immediate multivessel PCI and outcomes such as death, renal failure, and bleeding. It does not involve tranexamic acid (TXA), hemostatic pharmacodynamics, or any time-dependent effect of TXA after injury. Therefore, it neither supports nor contradicts the proposed mechanism about the diminishing hemostatic effect of TXA over time.",
          "key_findings": "Culprit-lesion-only PCI reduced the 30-day composite of death or severe renal failure compared to immediate multivessel PCI in patients with multivessel disease and cardiogenic shock after acute myocardial infarction; bleeding and stroke rates did not differ significantly between groups. No mention or analysis of TXA use or timing of hemostatic drug administration is provided.",
          "pmid": "29083953",
          "title": "PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The mechanism concerns time-dependent hemostatic/pharmacodynamic effects of tranexamic acid after injury. The abstract evaluates clinical effectiveness of endovascular thrombectomy for ischemic stroke between 6\u201324 hours after last known well, with no mention of tranexamic acid, hemostasis, or time-varying drug effect. Although timing from onset is analyzed, it relates to mechanical recanalization benefit, not TXA pharmacodynamics or diminishing hemostatic effect over time.",
          "key_findings": "Thrombectomy between 6\u201324 hours after stroke onset improved functional outcomes (adjusted common OR 2.54 for better mRS at 90 days) without increasing mortality or symptomatic intracerebral hemorrhage. Treatment effect was stronger in those randomized at 12\u201324 hours versus 6\u201312 hours. The study does not involve TXA or hemostatic drug mechanisms.",
          "pmid": "34774198",
          "title": "Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns the time-dependent hemostatic (antifibrinolytic) effect of tranexamic acid (TXA) after injury. The abstract instead studies timing of initiation of direct oral anticoagulants after ischemic stroke in atrial fibrillation, balancing ischemic versus hemorrhagic events. It does not involve TXA, antifibrinolysis, or pharmacodynamic waning of hemostatic effect with time from injury, so it neither supports nor contradicts the specific TXA-related mechanistic claim.",
          "key_findings": "Earlier initiation (day 3\u20134) of direct oral anticoagulants after AF-related ischemic stroke showed a numerically favorable composite of ischemic and hemorrhagic events compared with later starts within 14 days, but no clearly superior single start day was identified; the evidence suggested earlier is probably better within the 2\u2011week window. No data on tranexamic acid or time-dependent hemostatic pharmacodynamics were presented.",
          "pmid": "40163159",
          "title": "Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns the time-dependent hemostatic effect of tranexamic acid (TXA) after injury, whereas the abstract evaluates early vs late initiation of direct oral anticoagulants (DOACs) after ischemic stroke with atrial fibrillation. Although both involve timing of treatment relative to an acute event, TXA is an antifibrinolytic used to promote hemostasis, while DOACs are anticoagulants used to prevent thromboembolism. The abstract does not investigate TXA, trauma-related bleeding, or pharmacodynamic decay of a hemostatic effect over time, so it neither supports nor contradicts that specific mechanism.",
          "key_findings": "Early DOAC initiation (within 48h for minor/moderate stroke, days 6\u20137 for major stroke) versus later initiation showed similar rates of a composite outcome (recurrent ischemic stroke, symptomatic intracranial hemorrhage, extracranial bleeding, systemic embolism, or vascular death) across infarct sizes (minor, moderate, major) with no significant interaction by infarct size. Early treatment was not associated with higher adverse event rates, including symptomatic intracranial hemorrhage.",
          "pmid": "38805207",
          "title": "Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines timing of physical therapy after mild TBI and its impact on symptom improvement and sensorimotor balance, but it does not involve tranexamic acid (TXA), hemostasis, or pharmacodynamic principles of an antifibrinolytic drug. Therefore it neither supports nor contradicts the specific mechanism that TXA\u2019s hemostatic effect diminishes as time from injury increases.",
          "key_findings": "Earlier physical therapy (within 1 week) after mild TBI led to larger and faster improvements in patient-reported symptoms and sensorimotor balance measures compared to starting therapy after a 6\u2011week wait; both groups ultimately reached similar levels on patient-reported outcomes. The study suggests a therapeutic time window for rehabilitation, not for TXA or hemostatic pharmacology.",
          "pmid": "39693261",
          "title": "In People With Subacute Mild Traumatic Brain Injury, Earlier Physical Therapy Improved Symptoms at a Faster Rate Than Later Physical Therapy: Randomized Controlled Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses intracerebral hemorrhage, the importance of time to treatment in general, and the lack of proven therapies, but it does not mention tranexamic acid (TXA), hemostatic pharmacodynamics, or any time-dependent change in the hemostatic effect of TXA. Therefore it neither supports nor contradicts the specific proposed mechanism.",
          "key_findings": "The abstract notes that: (1) no current therapeutic modality has clearly improved long-term outcomes in small randomized trials for ICH; (2) time to treatment is likely very important for ICH therapy, by analogy to ischemic stroke; and (3) large randomized trials of current and new treatments are needed. It provides no TXA-specific or hemostasis-specific time-response data.",
          "pmid": "10757834",
          "title": "Intracerebral hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses surgical management and reconstruction principles for major peripheral nerve injuries and does not mention tranexamic acid (TXA), hemostatic effects, timing of pharmacologic intervention, or any time-dependent treatment efficacy. Therefore, it neither supports nor contradicts the proposed mechanism about diminishing TXA hemostatic effect with increasing time from injury.",
          "key_findings": "Major peripheral nerve injuries in the upper extremities cause significant morbidity; treatment focuses on tension-free nerve repairs using sutures, fibrin glue, nerve connectors, or grafts. Proper surgical principles can improve outcomes, but prognosis is generally guarded. No discussion of TXA, hemostasis, or time-sensitive pharmacodynamic effects.",
          "pmid": "23895717",
          "title": "Major peripheral nerve injuries.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses timing and protocols for surgical management and discharge of pretibial lacerations in elderly patients but does not mention tranexamic acid (TXA), hemostatic pharmacodynamics, or any time-dependent effect of TXA after injury. Therefore, it neither supports nor contradicts the proposed mechanism about diminishing hemostatic effect of TXA over time.",
          "key_findings": "The study advocates rapid, protocol-driven surgical intervention and minimized admissions for certain types of pretibial lacerations, reports on outcomes such as length of stay, mortality, donor-site over-grafting, and negative pressure wound therapy. No data are presented on TXA use, timing of TXA administration, or pharmacodynamic hemostatic effects relative to time from injury.",
          "pmid": "25175272",
          "title": "Pretibial lacerations: experience from a lower limb trauma centre and systematic review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract emphasizes the importance of early intervention and minimizing delays for REBOA in noncompressible hemorrhage, but it does not mention tranexamic acid (TXA), hemostatic drug effects, or pharmacodynamic changes over time. Its time-critical focus is about a procedural intervention (REBOA), not the diminishing hemostatic effect of TXA as time from injury increases.",
          "key_findings": "The review discusses: (1) high early mortality from noncompressible hemorrhage; (2) REBOA as an intervention whose effectiveness may depend on early deployment; (3) the concepts of the 'golden hour' and 'platinum 5 minutes' as rationales for urgent care; and (4) the need to minimize delays and optimize patient selection and prehospital strategies. No data or discussion about TXA pharmacodynamics or time-dependent hemostatic drug effects are provided.",
          "pmid": "39937037",
          "title": "REBOA for remote damage control resuscitation and the race against time.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses timing of cardiac surgery in infective endocarditis with intracranial hemorrhage and outcomes related to neurologic and cardiac complications. It does not mention tranexamic acid (TXA), hemostatic pharmacodynamics, or any time-dependent change in TXA effect after injury, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "The paper reviews limited observational data on early vs delayed valvular surgery in infective endocarditis patients with intracranial hemorrhage, noting literature that challenges the paradigm that surgery within 4 weeks leads to worse neurologic and mortality outcomes, and proposes a management algorithm for surgical timing. No pharmacologic hemostatic agents or TXA-related timing effects are addressed.",
          "pmid": "31422194",
          "title": "Surgical timing in infective endocarditis complicated by intracranial hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "medium",
          "reasoning": "The abstract addresses timing of a surgical intervention (early vs delayed VATS for retained hemothorax) and shows better outcomes with earlier surgery, but it does not involve tranexamic acid (TXA), hemostatic drug effects, or pharmacodynamic mechanisms of time-dependent hemostatic efficacy. Thus, it cannot directly support or contradict the proposed TXA-specific pharmacodynamic mechanism, even though both deal with timing after injury.",
          "key_findings": "Early VATS (within days 1\u20133) for traumatic retained hemothorax was associated with a significantly higher success rate compared with VATS on day 7 or later, and shorter hospital length of stay compared with both intermediate (days 4\u20136) and late (day 7+) intervention; short-term mortality was not reduced by earlier VATS.",
          "pmid": "31848631",
          "title": "Timing to perform VATS for traumatic-retained hemothorax (a systematic review and meta-analysis).",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses time-dependent treatment in acute ischemic stroke and early carotid artery stenting, but it does not mention tranexamic acid (TXA), hemostasis, or any pharmacodynamic relationship between time from injury and TXA\u2019s hemostatic effect. Thus it neither supports nor contradicts the proposed TXA-specific mechanism.",
          "key_findings": "The abstract notes that treatment of acute ischemic stroke due to high\u2011grade internal carotid artery stenosis is time\u2011dependent and reviews indications and results of early carotid artery stenting after neurologic symptom onset, highlighting concerns about hemorrhagic infarction risk and embolic risk with stenting versus endarterectomy.",
          "pmid": "29891028",
          "title": "Early carotid artery stenting after onset neurologic symptoms.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on timing and rapid treatment in acute ischemic stroke (e.g., tPA administration, endovascular thrombectomy) but does not discuss tranexamic acid (TXA), hemostatic effects, or how TXA efficacy changes with time from injury. The phrase 'time is brain' pertains to reperfusion therapies, not TXA pharmacodynamics.",
          "key_findings": "New studies support pre-hospital stroke treatment to enable earlier IV tPA; rapid CT perfusion/angiography to identify candidates for endovascular therapy; neuroendovascular thrombectomy for large vessel occlusion improves outcomes; guidelines for managing hemorrhagic transformation and cerebral edema; emphasis that faster stroke diagnosis and treatment improve outcomes (time is brain). None of these address TXA or its time-dependent hemostatic effect.",
          "pmid": "28646445",
          "title": "Update on Neurocritical Care of Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent hemostatic efficacy of tranexamic acid (TXA) after injury, whereas the abstract evaluates the effect of timing of magnesium administration on delayed cerebral ischemia and outcome after aneurysmal subarachnoid hemorrhage. Although both involve early pharmacologic intervention after a neurological event, the study does not investigate TXA, hemostasis, or time-dependent changes in TXA\u2019s hemostatic effect, so it neither supports nor contradicts the specific TXA mechanism.",
          "key_findings": "In an individual patient data meta-analysis of 5 trials (1981 patients) of magnesium after aneurysmal SAH, starting treatment at different time windows (<6, 6\u201312, 12\u201324, >24 hours) showed no beneficial effect on poor outcome or delayed cerebral ischemia. Adjusted risk ratios across timing groups were close to or above 1, and the authors concluded there is no justification for a new trial of early magnesium treatment after SAH.",
          "pmid": "26463689",
          "title": "Early Magnesium Treatment After Aneurysmal Subarachnoid Hemorrhage: Individual Patient Data Meta-Analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses that time from injury to definitive care is an independent predictor of outcome in traumatic vascular injury, and emphasizes timely diagnosis and intervention in general. However, it does not mention tranexamic acid (TXA), pharmacodynamics, or the time-dependent hemostatic efficacy of TXA specifically, so it neither supports nor contradicts the proposed TXA-related mechanism.",
          "key_findings": "Independent predictors of outcome in vascular injury include time from injury to definitive care; timely and appropriate diagnostic and therapeutic approaches are crucial to save life and preserve limb, but no specific mention of TXA or time-varying hemostatic drug effects is provided.",
          "pmid": "36980328",
          "title": "Diagnostic Approaches to Vascular Injury in Polytrauma-A Literature Review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns treatments for extravasation injuries in children and does not mention tranexamic acid (TXA), hemostatic effects, pharmacodynamics, or any time-dependent efficacy of a hemostatic agent. It discusses timing only in terms of heterogeneity in time between injury identification and treatment, without mechanistic or outcome data related to TXA or a similar hemostatic mechanism.",
          "key_findings": "The review found heterogeneous practices and limited evidence for various interventions (e.g., saline flush-out techniques, hyaluronidase, conservative management) for extravasation injuries in children. It notes variability in time gaps between injury identification and treatment but does not analyze how treatment timing affects the efficacy of any hemostatic drug or specifically TXA.",
          "pmid": "30175709",
          "title": "Treatment of extravasation injuries in infants and young children: a scoping review and survey.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ninjurytime",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Clinical trials, including secondary analyses from CRASH-2, have shown improved outcomes when TXA is administered early, with diminishing returns noted beyond 3 hours.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"time to treatment\" OR \"treatment delay\" OR \"injury time\" OR \"time from injury\") AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"administered\" OR \"diminishing\" OR \"secondary\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 1,
      "conflict_count": 1,
      "neutral_count": 18,
      "support_percentage": 5.0,
      "conflict_percentage": 5.0,
      "support_ratio": 0.05,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent benefits of tranexamic acid (TXA) in trauma/bleeding, with diminishing returns after 3 hours. The abstract evaluates tenecteplase, a thrombolytic, in ischemic stroke patients treated 4.5\u201324 hours after onset. Although both involve time windows for pharmacologic treatment in acute conditions, the study neither investigates TXA nor tests early versus late administration within a few hours; it examines a different drug, disease process, and time frame. Therefore, it does not provide direct evidence for or against the specific TXA timing mechanism.",
          "key_findings": "In Chinese patients with ischemic stroke due to large-vessel occlusion treated 4.5\u201324 hours after last-known-well, tenecteplase (0.25 mg/kg) versus standard medical therapy increased the proportion with modified Rankin Scale 0\u20131 at 90 days (33.0% vs 24.2%; RR 1.37, 95% CI 1.04\u20131.81; P=0.03), with similar 90-day mortality (13.3% vs 13.1%) and higher symptomatic intracranial hemorrhage (3.0% vs 0.8%). No data on TXA or on the effect of treatment before versus after 3 hours are presented.",
          "pmid": "38884324",
          "title": "Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.",
          "analysis_method": "llm"
        },
        {
          "stance": "conflict",
          "confidence": "medium",
          "reasoning": "The proposed mechanism states that early TXA administration (within 3 hours) improves outcomes. This trial specifically tested TXA initiated within 2 hours of injury in moderate/severe TBI and found no statistically significant improvement in 6\u2011month neurologic outcome, mortality, disability scores, or hemorrhage progression compared with placebo. While focused on TBI (a subset of trauma) and not all trauma patients, the results fail to show the benefit predicted by the mechanism in this early time window, thereby conflicting with the generalized claim of improved outcomes with early TXA.",
          "key_findings": "1) Multicenter RCT of 966 patients with moderate/severe TBI receiving TXA (bolus+maintenance or bolus-only) vs placebo, all initiated within 2 hours of injury. 2) Primary outcome (favorable 6\u2011month Glasgow Outcome Scale-Extended >4): 65% in TXA groups vs 62% in placebo; difference 3.5%, not statistically significant (P = .16). 3) No significant difference in 28-day mortality (14% TXA vs 17% placebo; difference -2.9%, 95% CI -7.9% to 2.1%; P = .26). 4) No significant difference in 6\u2011month Disability Rating Scale score (6.8 vs 7.6; difference -0.9, 95% CI -2.5 to 0.7; P = .29). 5) No significant difference in progression of intracranial hemorrhage (16% vs 20%; difference -5.4%, 95% CI -12.8% to 2.1%; P = .16). 6) Conclusion: Out-of-hospital TXA within 2 hours did not significantly improve 6\u2011month neurologic outcome in moderate/severe TBI.",
          "pmid": "32897344",
          "title": "Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses timing of blood product delivery within massive transfusion protocols and notes that shorter time to blood products improves outcomes, but it does not mention tranexamic acid (TXA), its timing, or differential benefit within or beyond 3 hours. Therefore it neither supports nor contradicts the specific mechanism about early TXA administration and diminishing returns after 3 hours.",
          "key_findings": "The review reports that: (1) massive transfusion protocols using balanced ratios (1:1:1 to 1:1:2 of plasma, platelets, and red blood cells) decrease mortality; (2) shorter time to blood product delivery and faster replacement of blood are associated with better outcomes; (3) pre-hospital treatment and adjuncts are discussed in general but without specific reference to TXA or time-dependent TXA effects.",
          "pmid": "33071074",
          "title": "Massive transfusion protocol in adult trauma population.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns consensus recommendations on operative vs non-operative treatment for ACL injuries and timing of ACL reconstruction relative to risk of secondary joint damage. It does not mention tranexamic acid (TXA), hemorrhage control, trauma resuscitation, or timing of pharmacologic interventions, and therefore does not provide evidence for or against the mechanism that early TXA administration improves outcomes with diminishing returns after 3 hours.",
          "key_findings": "International expert consensus recommends early anatomical ACL reconstruction in highly active patients to reduce risk of secondary meniscus and cartilage injuries, and supports non-operative management with structured rehabilitation for patients doing straight-plane activities, with surgery indicated if instability persists. No discussion of TXA or time-dependent pharmacologic treatment effects is provided.",
          "pmid": "32661128",
          "title": "Treatment after ACL injury: Panther Symposium ACL Treatment Consensus Group.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on prehospital resuscitation with blood products versus saline in trauma-related hemorrhagic shock and reports that most patients received tranexamic acid pre-randomization. It does not analyze timing of TXA administration, its relationship to outcomes, or any time-dependent effect (e.g., before vs after 3 hours). Therefore it neither supports nor contradicts the proposed mechanism about early TXA benefit with diminishing returns after 3 hours.",
          "key_findings": "In this trial of 432 adults with trauma-related hemorrhagic shock, patients were randomized to prehospital packed red blood cells plus lyophilized plasma versus 0.9% sodium chloride; the composite primary outcome (mortality or impaired lactate clearance) did not differ between groups. Approximately 90% of participants received tranexamic acid before randomization, but no data on timing of TXA administration or time-dependent outcome effects were reported.",
          "pmid": "35271808",
          "title": "Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent benefits of early tranexamic acid (TXA) administration after trauma/bleeding, particularly within 3 hours, whereas the abstract evaluates optimal timing of initiating direct oral anticoagulants after ischemic stroke due to atrial fibrillation. Although both involve time-sensitive pharmacologic therapy after an acute event, the study does not involve TXA, trauma, hemorrhage control, or the specific early-within-3-hours effect described in CRASH-2. Therefore it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "In a response-adaptive randomized trial of 200 patients with atrial-fibrillation\u2013related ischemic stroke, initiation of direct oral anticoagulation on days 3\u20134, 6, 10, or 14 post-stroke did not reveal a clearly superior single start day, but Bayesian analysis suggested earlier initiation (day 3\u20134) was more likely to be optimal within the 14-day window. This relates to timing of anticoagulation after ischemic stroke, not timing of TXA after trauma/bleeding.",
          "pmid": "40163159",
          "title": "Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "high",
          "reasoning": "The proposed mechanism states that clinical trials, including CRASH-2, show better outcomes with earlier TXA and diminishing benefit after 3 hours. This abstract directly examines outcome by time-to-TXA in a randomized trauma trial and finds that mortality benefit is greatest with earlier administration (up to ~90 minutes) and disappears thereafter, clearly demonstrating a time-dependent effect with diminishing returns as time from injury increases. Although it refines the window to <90 minutes rather than <3 hours, it strongly supports the core mechanistic claim that earlier TXA administration improves outcomes and that benefit diminishes with delay.",
          "key_findings": "In PATCH-Trauma trial exploratory analysis (n=1287), risk of death within 28 days increased as time from injury to first TXA dose increased. TXA given within 90 minutes reduced 28-day mortality (17% vs 25%; adjusted RR 0.64, 95% CI 0.50\u20130.82), whereas TXA given beyond 90 minutes showed no mortality reduction (adjusted RR 1.04, 95% CI 0.74\u20131.47). The authors conclude the optimal therapeutic window for TXA after trauma may be within 90 minutes.",
          "pmid": "40751727",
          "title": "Tranexamic Acid Timing and Mortality Impact After Trauma.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses neuroinflammation and timing-related immunomodulation after traumatic brain injury but does not mention tranexamic acid (TXA), its administration timing, or outcome effects within or beyond 3 hours. Therefore it neither supports nor contradicts the proposed TXA-specific timing mechanism.",
          "key_findings": "The review proposes a framework for targeted immunomodulation after TBI that considers time from injury, mechanism of injury, and secondary insults. It summarizes animal and human studies on immune response dynamics and neuroinflammation, including inflammasomes, microglial polarization, and glymphatic clearance, and notes that general anti-inflammatory agents have failed to improve TBI outcomes. No data on TXA, hemostatic therapy, or early vs late TXA administration are presented.",
          "pmid": "28186177",
          "title": "The far-reaching scope of neuroinflammation after traumatic brain injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent benefits of early tranexamic acid (TXA) administration after trauma/bleeding, particularly the diminishing benefit beyond 3 hours as shown in CRASH-2. The abstract instead evaluates intravenous alteplase (a thrombolytic) given within 4.5 hours before endovascular thrombectomy in acute ischemic stroke. It does not investigate TXA, trauma, hemorrhage control, or time-cutoff effects beyond or within 3 hours for TXA, so it neither supports nor contradicts the specific TXA timing mechanism.",
          "key_findings": "In acute ischemic stroke due to large-vessel occlusion, endovascular thrombectomy alone was noninferior to thrombectomy plus intravenous alteplase (0.9 mg/kg within 4.5 hours of symptom onset) for 90-day functional outcome, with similar mortality but lower rates of successful reperfusion in the thrombectomy-alone group.",
          "pmid": "32374959",
          "title": "Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent benefits of early tranexamic acid (TXA) administration after trauma/bleeding, particularly before 3 hours, based on CRASH-2. This abstract evaluates time-dependent effects of thrombolytic therapy (rt-PA and other thrombolytics) in acute ischaemic stroke. Although it also finds greater benefit when treatment is started within 3 hours and diminishing benefit later, it studies a completely different class of drugs (thrombolytics vs antifibrinolytic TXA) in a different clinical context (stroke vs trauma/hemorrhage). Thus it does not directly support or refute the specific TXA-based mechanism, even if the temporal pattern is superficially similar.",
          "key_findings": "In acute ischaemic stroke, thrombolytic therapy given up to 6 hours after stroke reduces death or dependency, but treatment within 3 hours yields substantially greater benefit (OR 0.66 for death or dependency within 3 hours vs 0.85 up to 6 hours). The review does not involve TXA or trauma-related bleeding and therefore does not directly address the proposed mechanism about early TXA use and outcomes beyond 3 hours.",
          "pmid": "25072528",
          "title": "Thrombolysis for acute ischaemic stroke.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates an early sepsis resuscitation protocol involving fluids, vasopressors, and transfusion in Zambia and its effect on mortality. It does not involve tranexamic acid (TXA), timing of TXA administration, trauma, or hemorrhage, nor does it analyze outcome differences based on treatment within or beyond 3 hours. Therefore, it neither supports nor contradicts the proposed mechanism about early TXA use and time-dependent benefit seen in CRASH-2.",
          "key_findings": "An early sepsis resuscitation protocol (higher fluid volumes, more vasopressor use) increased in-hospital mortality compared with usual care among hypotensive adults with sepsis in a resource-limited setting (48.1% vs 33.0% mortality; RR 1.46). No mention of TXA, trauma, bleeding control, or timing-dependent effects of TXA.",
          "pmid": "28973227",
          "title": "Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses the diagnosis and management of irreducible Galeazzi fracture-dislocations, focusing on mechanical blocks to distal radioulnar joint reduction and tendon/fracture fragment entrapment. It does not mention tranexamic acid (TXA), timing of TXA administration, clinical trials, or outcome differences related to early versus late TXA use. Therefore, it neither supports nor contradicts the proposed mechanism about time-dependent TXA efficacy.",
          "key_findings": "The study reviews 17 cases of irreducible Galeazzi fracture-dislocations, finding that high-energy trauma is the usual cause, most dorsally dislocated DRUJs are blocked by extensor tendon entrapment or fracture fragments, some volar dislocations involve ulnar head entrapment, and over half of irreducible DRUJs were missed pre- or intraoperatively. No pharmacologic interventions or TXA-related outcomes are reported.",
          "pmid": "29185351",
          "title": "Irreducible Galeazzi Fracture-Dislocations.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses evidence-based practice and perioperative management for pediatric tonsillectomy in general, without mentioning tranexamic acid (TXA), timing of TXA administration, trauma, or outcome differences based on administration within or beyond 3 hours. Therefore, it neither supports nor conflicts with the proposed mechanism about early TXA administration improving outcomes.",
          "key_findings": "The article reviews indications, perioperative management, and surgical techniques for pediatric tonsillectomy, aiming to reduce perioperative complications, but does not address TXA use or time-dependent effects of TXA.",
          "pmid": "22980686",
          "title": "Evidence-based practice: pediatric tonsillectomy.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns time-dependent benefits of early tranexamic acid (TXA) administration after trauma (particularly within 3 hours), whereas the abstract evaluates timing of physical therapy initiation after mild traumatic brain injury. Although both involve timing of interventions after injury, the study does not involve TXA, hemostasis, or pharmacologic treatment windows, so it neither supports nor contradicts the specific TXA-related mechanism.",
          "key_findings": "Earlier physical therapy (initiated within 1 week) after mild TBI led to faster and in some measures greater improvement in symptoms and sensorimotor balance outcomes compared with later physical therapy (initiated after a 6-week wait), suggesting a therapeutic window for rehabilitation but providing no data on TXA administration or its time-dependent effects.",
          "pmid": "39693261",
          "title": "In People With Subacute Mild Traumatic Brain Injury, Earlier Physical Therapy Improved Symptoms at a Faster Rate Than Later Physical Therapy: Randomized Controlled Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses time-limited eligibility for tPA within 3 hours of ischemic stroke onset, but it does not mention tranexamic acid (TXA), trauma, the CRASH-2 trial, or outcome differences based on timing of TXA administration. Therefore it neither supports nor contradicts the proposed TXA-specific early-administration mechanism.",
          "key_findings": "tPA was first approved for patients with recent (<3 h) cerebral vessel occlusion; advances in clot retrieval and various neuroprotective and rehabilitative strategies are under clinical investigation for ischemic stroke.",
          "pmid": "28674985",
          "title": "Stroke: Basic and Clinical.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses time-dependent benefits of reperfusion therapies in acute ischemic stroke and how treatment delays affect outcomes, but it does not mention tranexamic acid (TXA), trauma, CRASH-2, or any hemostatic drug trials. Therefore, it neither supports nor conflicts with the specific mechanism about early TXA administration improving outcomes within 3 hours.",
          "key_findings": "The abstract reports that: (1) IV alteplase is effective when given within 4.5 hours of stroke onset; (2) thrombectomy shows benefit within 6\u20138 hours; (3) treatment delay adversely affects outcomes; and (4) DAWN trial shows benefit of thrombectomy 6\u201324 hours in selected patients with persistent penumbra. None of these findings involve TXA or the CRASH-2 context.",
          "pmid": "29037436",
          "title": "Which imaging before reperfusion strategy?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses timing of surgery for hip fractures and associated outcomes (e.g., avascular necrosis, complications, functional recovery), but it does not mention tranexamic acid (TXA), antifibrinolytics, or time-dependent pharmacologic treatment effects. Therefore, it neither supports nor conflicts with the proposed mechanism about early TXA administration improving outcomes within 3 hours.",
          "key_findings": "Studies in the abstract examine whether surgery within 8\u201312 hours reduces risk of avascular necrosis in femoral neck fractures, but results are contradictory. The paper emphasizes prompt surgery for pain relief and rehabilitation, discusses failure rates of internal fixation, indications for arthroplasty, complication rates, and functional outcomes in non-elderly hip fracture patients, without any reference to TXA or time-to-drug administration effects.",
          "pmid": "29983171",
          "title": "Hip fractures in the non-elderly-Who, why and whither?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses pathophysiology and biomaterial-based repair strategies for spinal cord injury and its temporal phases, but it does not mention tranexamic acid (TXA), clinical trials, timing of pharmacologic interventions within hours of injury, or outcome changes related to early versus late drug administration. Therefore, it neither supports nor contradicts the proposed timing-dependent effect of TXA seen in CRASH-2.",
          "key_findings": "The abstract describes primary and secondary spinal cord injury, outlines acute to chronic phases, notes inflammatory cell infiltration, cytokine release, and glial scar formation as barriers to regeneration, and reviews biomaterials (natural/synthetic polymers, nanomaterials) and tissue-engineering strategies for spinal cord repair. No data on TXA, hemostatic agents, trauma clinical trials, or effects of intervention timing within 3 hours are provided.",
          "pmid": "33497713",
          "title": "Biomaterials and strategies for repairing spinal cord lesions.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns timing of TXA administration and its effect on clinical outcomes within and beyond 3 hours. This abstract focuses on dose-dependent risk of thromboembolic events and notes time from injury to TXA administration as an independent risk factor, but it does not quantify outcome differences by early vs late administration or examine benefit diminishing after 3 hours. Thus, it neither directly supports nor contradicts the specific early-use benefit mechanism.",
          "key_findings": "In a randomized, double-blind, placebo-controlled trial of severe trauma patients receiving placebo, 2-g, or 4-g IV TXA bolus, adjusted analyses showed higher thromboembolism risk with TXA: HR 3.20 (95% CI 1.12\u20139.11) for 2 g and HR 5.33 (95% CI 1.94\u201314.63) for 4 g versus placebo. Event curves showed a higher probability of thromboembolism for both TXA doses. Time from injury to TXA administration, BMI, and total blood products transfused were independently associated with thromboembolism, but the abstract does not detail timing thresholds or outcomes specifically within versus beyond 3 hours.",
          "pmid": "35765921",
          "title": "The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates timing to angioembolization in pelvic fracture patients and compares weekday vs off\u2011hours outcomes. It does not involve tranexamic acid (TXA), does not assess pharmacologic hemostasis, and does not analyze outcome differences related to time of TXA administration. Therefore, it neither supports nor contradicts the proposed mechanism about early TXA use and outcome.",
          "key_findings": "In patients with pelvic fractures and retroperitoneal hematoma, angioembolization was performed in 61% of cases; timing to angioembolization was similar between weekday and off\u2011hours admissions and mortality did not differ. CT contrast extravasation correlated well with angiographic findings. No mention or analysis of TXA administration or time\u2011dependent effects of TXA.",
          "pmid": "30928125",
          "title": "Pelvic fractures with associated retroperitoneal hematoma: time until angioembolization and results.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ihr",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Tachycardia (heart rate > 100 bpm) is a physiological response to hemorrhage and can indicate active bleeding, which TXA can potentially mitigate by reducing fibrinolysis and stabilizing clots.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"heart rate\" OR \"initial heart rate\" OR tachycardia OR bradycardia OR pulse) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"physiological\" OR \"fibrinolysis\" OR \"stabilizing\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 1,
      "conflict_count": 1,
      "neutral_count": 18,
      "support_percentage": 5.0,
      "conflict_percentage": 5.0,
      "support_ratio": 0.05,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract is a general review on heart rate variability and autonomic regulation. It does not discuss tachycardia as a specific physiological response to hemorrhage, does not address active bleeding, fibrinolysis, clot stabilization, or tranexamic acid (TXA). Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "The review describes heart rate variability as a marker of autonomic nervous system function, notes that low HRV is associated with pathological cardiovascular conditions and higher mortality, and explains that HRV is influenced by multiple physiological, psychological, environmental, lifestyle, and genetic factors. No mention is made of hemorrhage, tachycardia due to blood loss, fibrinolysis, or TXA.",
          "pmid": "33390146",
          "title": "Analysis of Heart Rate Variability and Implication of Different Factors on Heart Rate Variability.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses diagnostic criteria, pathophysiology, and characterization of postural orthostatic tachycardia syndrome (POTS), focusing on orthostatic tachycardia as a syndrome of orthostatic intolerance. It does not address tachycardia as a physiological response to hemorrhage, active bleeding, fibrinolysis, clot stabilization, or the effects of tranexamic acid (TXA). Therefore it neither supports nor contradicts the proposed mechanism about tachycardia indicating hemorrhage that TXA may mitigate.",
          "key_findings": "The abstract notes that POTS involves orthostatic tachycardia and challenges in defining its diagnostic criteria, pathophysiology, and relationship between symptoms and physiological findings. It emphasizes that POTS is not simply intermittent orthostatic tachycardia, but must be characterized over time with reproducibility. No mention is made of hemorrhage, bleeding, fibrinolysis, clot stability, or TXA.",
          "pmid": "32222376",
          "title": "Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates catheter-directed, low-dose fibrinolysis for pulmonary embolism, focusing on RV/LV ratio, pulmonary pressures, thrombus burden, and bleeding complications. It does not discuss tachycardia as a response to hemorrhage, active bleeding as indicated by heart rate, or the effects of tranexamic acid (TXA) on fibrinolysis or clot stabilization.",
          "key_findings": "Ultrasound-facilitated catheter-directed fibrinolysis with low-dose t-PA in acute massive and submassive PE reduced RV/LV diameter ratio, pulmonary artery systolic pressure, and thrombus burden, with one severe and 16 moderate bleeding events, and no intracranial hemorrhages.",
          "pmid": "26315743",
          "title": "A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses maternal cardiovascular dysfunction and hemodynamics in preeclampsia but does not address tachycardia as a physiological response to hemorrhage, active bleeding, fibrinolysis, clot stabilization, or the effects of tranexamic acid (TXA). Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "The review describes two hemodynamic phenotypes of preeclampsia related to maternal cardiovascular dysfunction, differences between normal and pathologic hemodynamic changes in pregnancy, and the use of noninvasive techniques to study arterial and cardiac function. It does not mention tachycardia as a marker of hemorrhage, active bleeding, or TXA-mediated modulation of fibrinolysis.",
          "pmid": "34774281",
          "title": "Preeclampsia has two phenotypes which require different treatment strategies.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses fetal heart rate responses (tachycardia vs bradycardia) to hypoxia and decelerations in labor, focusing on chemoreflexes, myocardial hypoxia, and obstetric management. It does not address hemorrhage, active bleeding, fibrinolysis, clot stabilization, or the effects of tranexamic acid (TXA). Therefore, it neither supports nor contradicts the proposed mechanism linking tachycardia as a marker of hemorrhage that TXA could ameliorate.",
          "key_findings": "In gradually evolving fetal hypoxia, catecholamine-mediated tachycardia increases cardiac output and redistributes oxygenated blood to central organs; in sudden, profound hypoxia, an immediate vagally mediated bradycardia reduces myocardial workload, and prolonged decelerations/bradycardia are associated with risk of hypoxic-ischemic injury. Management focuses on identifying acute intrapartum accidents and reversible causes, with intrauterine resuscitation and urgent delivery where needed.",
          "pmid": "37270260",
          "title": "Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses cardiovascular and pulmonary physiology in breath-hold diving, including diving bradycardia, vasoconstriction, and pulmonary injury, but does not mention hemorrhage, tachycardia as a response to blood loss, active bleeding, fibrinolysis, clot stability, or the effects of tranexamic acid (TXA). Therefore it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Breath-hold diving induces immersion-related blood shift into thoracic vasculature and autonomic responses such as diving bradycardia, peripheral vasoconstriction, and splenic contraction. Pulmonary squeeze can cause hemoptysis, and hypoxia/hypercapnia drive apnea breakpoints. No data are presented on hemorrhage-induced tachycardia, active bleeding management, fibrinolysis, or TXA.",
          "pmid": "29687909",
          "title": "Breath-Hold Diving.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses wearable pressure sensors for monitoring pulse waves and cardiovascular status but does not address hemorrhage, tachycardia as a response to bleeding, fibrinolysis, clot stabilization, or the effects of tranexamic acid. Therefore it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Wearable flexible pressure sensors (triboelectric, piezoelectric, magnetoelastic, piezoresistive, capacitive, optical) can monitor physiological pulse waveforms continuously and are being developed for cardiovascular condition assessment and personalized healthcare.",
          "pmid": "35044014",
          "title": "Wearable Pressure Sensors for Pulse Wave Monitoring.",
          "analysis_method": "llm"
        },
        {
          "stance": "conflict",
          "confidence": "medium",
          "reasoning": "The abstract states that in the pathophysiology of syncope, the ability to vasoconstrict is important and that heart rate responses are of much less physiological significance, implying tachycardia is not a key indicator or driver of hemodynamic status in this context. This conflicts with the proposed mechanism that emphasizes tachycardia as an important physiological response to hemorrhage and active bleeding (a critical hemodynamic disturbance), even though the abstract is about syncope rather than hemorrhage specifically.",
          "key_findings": "1) Blood pressure is regulated mainly by baroreceptor reflexes controlling vascular resistance and heart rate. 2) The ability to vasoconstrict powerfully is important in resisting syncope; heart rate responses are of much less physiological significance. 3) There is a transition from vasoconstriction and tachycardia to vasodilatation and bradycardia in syncope, with tachycardia not highlighted as a primary protective factor.",
          "pmid": "15480926",
          "title": "Pathophysiology of syncope.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses fetal heart rate patterns as indicators of fetal oxygenation, hypoxemia, and acidosis, but does not address tachycardia as a response to hemorrhage, active bleeding, or the role of TXA, fibrinolysis, or clot stabilization. Thus it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Fetal heart rate tracings reflect fetal brain oxygenation status and adaptive responses to progressive hypoxemia and acidosis; mechanisms of oxygen delivery to the fetus and their disruption are reviewed, but hemorrhage, tachycardia as a bleeding marker, and TXA are not mentioned.",
          "pmid": "32618597",
          "title": "Physiology of Fetal Heart Rate Monitoring.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses apnea of prematurity, central neural control of breathing, and associated bradycardia and desaturation, but does not mention tachycardia, hemorrhage, active bleeding, fibrinolysis, clot stabilization, or tranexamic acid (TXA). It therefore neither supports nor contradicts the proposed mechanism linking tachycardia as a response to hemorrhage that TXA might mitigate.",
          "key_findings": "Apnea of prematurity is attributed to immature central neural control circuits; the review covers the pathogenesis of apnea, the interplay of apnea, bradycardia, and desaturation, and mechanisms and therapies for central, mixed, and obstructive apnea, as well as long-term consequences of intermittent hypoxia. No discussion of hemorrhage, tachycardia, or TXA-related mechanisms is provided.",
          "pmid": "23720269",
          "title": "Apnea of prematurity.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on exercise physiology in elite rowers, including aerobic/anaerobic capacity, power output, ventilation, and metabolic responses. It does not discuss hemorrhage, tachycardia as a response to bleeding, clot formation, fibrinolysis, or the effects of tranexamic acid, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Elite rowers exhibit high VO2max, large anaerobic capacity, high power output, high ventilation, and characteristic race pacing with initial and final sprints and high lactate levels. No mention is made of hemorrhage, tachycardia due to blood loss, clot stabilization, fibrinolysis, or TXA.",
          "pmid": "6390606",
          "title": "Applied physiology of rowing.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses interoception, emotional experience, and brain regions involved in perceiving bodily states, but it does not address hemorrhage, tachycardia as a physiological response to blood loss, active bleeding, fibrinolysis, clot stabilization, or the effects of TXA. Therefore it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "Imaging studies show that activity in anterior insula and anterior cingulate correlates with individual differences in interoception (heartbeat detection) and trait emotion measures; peripheral autonomic changes are not strictly necessary for emotional experience; a model is proposed for how interoception contributes to emotional phenomenology and awareness.",
          "pmid": "16003122",
          "title": "Interoception in emotional experience.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses exercise-related cardiac complications, sudden cardiac death, and CPR training in athletes. It does not address hemorrhage, active bleeding, fibrinolysis, clot stabilization, or the use of tranexamic acid (TXA), nor does it link tachycardia to hemorrhage or bleeding control.",
          "key_findings": "Overview of the athlete's heart in young athletes; emphasis on recognizing causes of exercise-related cardiac complications and sudden cardiac death; recommendation that coaches and athletic personnel learn and regularly update CPR skills to prevent exercise-related cardiac deaths.",
          "pmid": "9330810",
          "title": "The athlete's heart.",
          "analysis_method": "llm"
        },
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The proposed mechanism states that tachycardia (>100 bpm) is a physiological response to hemorrhage and can indicate active bleeding. The abstract explicitly describes that simple hemorrhage triggers a Phase 1 baroreflex response characterized by tachycardia and increased vascular resistance to maintain blood pressure. This directly supports the part of the mechanism that links hemorrhage to tachycardia as a physiological response and indicator of active blood loss. The abstract does not address TXA or fibrinolysis, so it neither supports nor refutes the TXA-related component, but it does substantively support the hemorrhage\u2013tachycardia portion of the mechanism.",
          "key_findings": "The article states that 'simple' hemorrhage causes a biphasic response: in Phase 1, mean arterial pressure is maintained by the baroreflex with tachycardia and increased vascular resistance, followed by a Phase 2 with decreased vascular resistance and bradycardia. This establishes tachycardia as part of the early physiological response to blood loss.",
          "pmid": "25038158",
          "title": "Haemodynamic changes in trauma.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses neural circulatory control and vasovagal syncope, focusing on inappropriate cardiac slowing (bradycardia), loss of vasomotor tone, and hypotension due to autonomic reflexes. It does not address tachycardia as a physiological response to hemorrhage, does not involve active bleeding, fibrinolysis, clot stabilization, or the effects of TXA. Therefore it neither supports nor contradicts the proposed mechanism linking tachycardia in hemorrhage to TXA\u2019s action on fibrinolysis.",
          "key_findings": "Vasovagal syncope involves inappropriate cardiac slowing from increased vagal activity and arteriolar dilatation from reduced sympathetic activity, leading to hypotension and syncope. There is strong evidence for early loss of vasomotor tone; baroreflex modulation remains until offset by a depressor reflex with relative bradycardia. Interventions like atropine or pacing can prevent bradycardia but have not been shown to prevent hypotension.",
          "pmid": "9080507",
          "title": "Neural circulatory control in vasovagal syncope.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates whether tachycardia predicts mortality in trauma-related hemorrhagic shock and finds no significant linear association. The proposed mechanism concerns tachycardia as a physiological response indicating active bleeding that TXA might mitigate by stabilizing clots. This paper does not examine TXA, fibrinolysis, clot stability, or the use of heart rate to guide TXA therapy; it only questions the predictive value and linear relationship of heart rate with mortality. Therefore, it neither supports nor contradicts the specific mechanistic claim about TXA\u2019s role in relation to tachycardia.",
          "key_findings": "Meta-regression of 19 studies found no significant relation (p=0.847) between early post-injury heart rate and mortality in hemorrhagic trauma patients, and subgroup analysis of patients receiving blood products also did not show a linear association between heart rate and mortality. The authors note a lack of linear association between postinjury heart rate and mortality and highlight the multiphasic heart rate response to bleeding, suggesting ATLS\u2019s linear HR\u2013shock classification may be oversimplified.",
          "pmid": "36261235",
          "title": "Predictive value of tachycardia for mortality in trauma-related haemorrhagic shock: a systematic review and meta-regression.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract links noise exposure in premature infants to increased heart rate as a stress response, but it does not involve hemorrhage, active bleeding, fibrinolysis, clot stabilization, or TXA. Therefore it neither supports nor contradicts the specific mechanism that tachycardia due to hemorrhage can serve as an indicator of bleeding that TXA might mitigate.",
          "key_findings": "Premature infants exposed to continuous loud noise exhibit negative physiological responses, including increased heart and respiratory rates and decreased oxygen saturation; reducing noise improves the environment for maturation and recovery.",
          "pmid": "12903694",
          "title": "Noise and the premature infant: physiological effects and practice implications.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses psychoneuroendocrine and psychosocial mechanisms in Takotsubo syndrome, focusing on catecholamine-mediated myocardial stunning and autonomic nervous system hyperexcitability. It does not address hemorrhage, tachycardia as a response to blood loss, active bleeding, fibrinolysis, clot stabilization, or the effects of TXA. Therefore it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "Takotsubo syndrome is linked to emotional or physiological stress, supraphysiological catecholamine levels, autonomic nervous system hyperexcitability, and chronic stress-related dysregulation of the hypothalamic-pituitary-adrenal axis. Psychosocial factors such as chronic or traumatic stress and anxiodepressive disorders are associated with its pathogenesis.",
          "pmid": "27411402",
          "title": "Psychosocial and psychoneuroendocrinal aspects of Takotsubo syndrome.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses how inspiration-induced negative intrathoracic pressure modulates cardiovascular function and can be used to treat hypovolemic states, including hemorrhagic shock. However, it does not address tachycardia as a physiological response to hemorrhage, does not discuss active bleeding as indicated by heart rate, and does not mention tranexamic acid (TXA), fibrinolysis, or clot stabilization. Thus it is related to circulatory responses in hemorrhagic shock but does not provide evidence for or against the specific proposed TXA-related mechanism.",
          "key_findings": "Inspiration-generated negative intrathoracic pressure (within a certain range) can enhance venous return, cardiac output, and cerebral blood flow, and is being translated into technologies to treat hypovolemic conditions including hemorrhagic shock. Excessively large negative pressures can be hemodynamically harmful.",
          "pmid": "31225967",
          "title": "Mechanisms of inspiration that modulate cardiovascular control: the other side of breathing.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses associations between elevated resting heart rate and vascular endothelial aging/atherosclerosis, but it does not address tachycardia as a physiological response to hemorrhage, active bleeding, tranexamic acid (TXA), fibrinolysis, or clot stabilization. It focuses on chronic cardiovascular risk rather than acute hemorrhagic physiology or TXA-modifiable mechanisms.",
          "key_findings": "Resting heart rate above 70 bpm is associated with increased cardiovascular events and reduced lifespan; each cardiac cycle imposes mechanical stress on arteries, potentially damaging endothelium and promoting atherogenesis; reducing heart rate may protect endothelium by lowering mechanical stress and prolonging laminar flow; hypertension adds to mechanical stress and accelerates atherogenesis.",
          "pmid": "19586943",
          "title": "Vascular endothelial ageing, heartbeat after heartbeat.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ihr",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "The CRASH-2 trial demonstrated an overall mortality benefit from TXA in trauma; thus, identifying subgroups with potentially higher fibrinolysis rates could optimize benefit from TXA.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"heart rate\" OR \"initial heart rate\" OR tachycardia OR bradycardia OR pulse) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"fibrinolysis\" OR \"demonstrated\" OR \"potentially\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates apixaban versus standard anticoagulation for thromboprophylaxis in pediatric heart disease and reports bleeding and thromboembolic outcomes. It does not involve trauma patients, tranexamic acid (TXA), fibrinolysis rates, or subgroup identification based on fibrinolytic profiles, so it neither supports nor contradicts the proposed mechanism regarding optimizing TXA benefit using fibrinolysis-based subgroups from CRASH-2.",
          "key_findings": "In a phase 2 open-label randomized trial of 192 children with congenital or acquired heart disease, apixaban was compared with vitamin K antagonists or low-molecular-weight heparin for 1 year. Major or clinically relevant nonmajor bleeding occurred in 0.8% of apixaban patients versus 4.8% of SOC patients; overall bleeding events were more frequent with apixaban, driven by minor bleeding. No thromboembolic events or deaths occurred in either arm. Apixaban pharmacokinetics in children were consistent with adult exposures, supporting its use as an alternative thromboprophylaxis strategy in pediatric heart disease.",
          "pmid": "38057072",
          "title": "Apixaban for Prevention of Thromboembolism in Pediatric Heart\u00a0Disease.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses low-intensity pulsed ultrasound (LIPUS) for tissue healing, inflammation modulation, and neuromodulation. It does not mention trauma, tranexamic acid (TXA), fibrinolysis, coagulation, or mortality outcomes, and therefore provides no evidence for or against optimizing TXA use in trauma based on fibrinolysis subgroups.",
          "key_findings": "LIPUS can accelerate fracture healing, aid soft-tissue regeneration, inhibit inflammatory responses, and has potential neuromodulatory applications, with minimal thermal effects and noninvasive physical stimulation. No data are presented on trauma-related fibrinolysis, TXA treatment, or mortality.",
          "pmid": "30596564",
          "title": "A Review of Low-Intensity Pulsed Ultrasound for Therapeutic Applications.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates safety and efficacy of catheter-directed low-dose fibrinolysis (tPA) for pulmonary embolism, not the use of tranexamic acid (TXA) in trauma or the identification of high-fibrinolysis trauma subgroups to optimize TXA benefit. It does not address CRASH-2, antifibrinolytics, trauma populations, or stratification by fibrinolytic activity.",
          "key_findings": "In 150 patients with massive or submassive PE, ultrasound-facilitated, catheter-directed low-dose tPA reduced RV/LV ratio, pulmonary artery systolic pressure, and thrombus burden, with one severe and 16 moderate bleeding events and no intracranial hemorrhage.",
          "pmid": "26315743",
          "title": "A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation and examines outcomes of ischemic stroke, composite cardiovascular events, mortality, and bleeding. It does not involve trauma, tranexamic acid (TXA), fibrinolysis, or subgroup identification based on fibrinolytic activity, and therefore neither supports nor contradicts the proposed mechanism related to optimizing TXA use in trauma via fibrinolysis-based subgrouping.",
          "key_findings": "Meta-analysis of NOAH-AFNET 6 and ARTESiA showed that oral anticoagulation (edoxaban or apixaban) reduced ischemic stroke (RR 0.68) and a composite cardiovascular outcome (RR 0.85) in patients with device-detected atrial fibrillation, without reducing cardiovascular or all-cause mortality, and increased major bleeding (RR 1.62). No data on trauma, TXA, or fibrinolysis subgroups are presented.",
          "pmid": "37952187",
          "title": "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies music therapy for pain, anxiety, and vital signs after cardiac valve surgery. It does not mention tranexamic acid (TXA), trauma, fibrinolysis, or subgroup identification based on fibrinolysis rates, so it neither supports nor contradicts the proposed mechanism related to TXA use in trauma patients.",
          "key_findings": "In a randomized controlled trial of 86 post\u2013cardiac valve replacement patients, a 15-minute music intervention given three times, in addition to standard care, significantly reduced pain, anxiety, systolic blood pressure, heart rate, and respiratory rate compared with standard care alone, with no significant change in diastolic blood pressure.",
          "pmid": "36650441",
          "title": "Music therapy for pain and anxiety in patients after cardiac valve replacement: a randomized controlled clinical trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses methods for monitoring athletic training loads, including internal and external load measures, TRIMP, session RPE, and wearable sensors. It does not address trauma, tranexamic acid (TXA), fibrinolysis, mortality, or subgroup identification in the context of the CRASH-2 trial or any hemostatic mechanisms.",
          "key_findings": "The paper reviews historical and current approaches to monitoring training load in athletes, such as observation of workouts, interval training indices, metabolic threshold testing, TRIMP, session RPE, and wearable sensor data, emphasizing issues of standardization, information overload, and practical utility for coaches.",
          "pmid": "28253038",
          "title": "Monitoring Training Loads: The Past, the Present, and the Future.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates apixaban versus aspirin for stroke prevention in subclinical atrial fibrillation stratified by CHA2DS2-VASc score. It does not involve trauma, tranexamic acid (TXA), fibrinolysis rates, or subgroup optimization of TXA benefit based on fibrinolytic status. Therefore, it neither supports nor contradicts the proposed mechanism related to TXA use in trauma.",
          "key_findings": "In ARTESiA, apixaban reduced stroke/systemic embolism compared with aspirin but increased major bleeding in patients with subclinical AF. Benefit\u2013risk varied by CHA2DS2-VASc: patients with score >4 derived clear net benefit, those with <4 had net harm, and those with score =4 represented an intermediate group. No data on TXA, trauma, or fibrinolysis are presented.",
          "pmid": "39019530",
          "title": "Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial\u00a0Fibrillation: Insights From ARTESiA.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns autonomic dysreflexia, cardiovascular dysfunction, and renin-angiotensin system involvement after high-level spinal cord injury, with discussion of neural cell transplantation and RAS inhibition. It does not mention tranexamic acid (TXA), trauma-related fibrinolysis, CRASH-2, mortality outcomes, or stratification of patients by fibrinolysis rates, so it neither supports nor contradicts the proposed TXA-related mechanism.",
          "key_findings": "High-level SCI leads to autonomic dysreflexia due to loss of supraspinal control, maladaptive plasticity, and excessive sympathetic activity; the renin-angiotensin system is upregulated post-injury and may contribute to cardiovascular dysregulation; transplantation of embryonic presympathetic neurons into the injured spinal cord in rodent models reduces episodes and severity of autonomic dysreflexia, though hormonal dysregulation and baroreflex dysfunction persist; combining cell transplantation with renin-angiotensin system inhibition is proposed as a therapeutic strategy. None of these findings relate to TXA use in trauma or fibrinolysis-based patient subgroups.",
          "pmid": "38084412",
          "title": "Autonomic Dysreflexia in Spinal Cord Injury: Mechanisms and Prospective Therapeutic Targets.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses autonomic dysfunction after intracerebral hemorrhage, its mechanisms, assessment, and general treatment strategies focused on restoring sympathetic\u2013parasympathetic balance. It does not mention tranexamic acid (TXA), trauma, fibrinolysis, CRASH-2, or stratifying patients by fibrinolytic status, so it neither supports nor contradicts the proposed mechanism about optimizing TXA benefit in trauma via identifying high-fibrinolysis subgroups.",
          "key_findings": "The review summarizes: (1) that autonomic dysfunction following intracerebral hemorrhage is common and associated with worse neurological and systemic outcomes; (2) that central autonomic network structures (e.g., insular cortex, hypothalamus, brainstem nuclei) are involved; (3) that autonomic function can be assessed via heart rate variability, baroreflex sensitivity, skin sympathetic activity, and plasma catecholamines; and (4) that risk stratification and interventions targeting autonomic balance may improve outcomes in ICH. No data on TXA, trauma-related hemorrhage, fibrinolysis, or TXA-response subgroups are presented.",
          "pmid": "38372446",
          "title": "Autonomic dysfunction and treatment strategies in intracerebral hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract is a case report of cerebral venous sinus thrombosis and subdural hematoma in a patient with systemic lupus erythematosus, focusing on diagnosis and treatment with anticoagulation, steroids, and IVIG. It does not discuss tranexamic acid (TXA), trauma, fibrinolysis rates, CRASH-2, or stratification of patients for TXA benefit. Therefore it neither supports nor contradicts the proposed mechanism about optimizing TXA use in trauma based on fibrinolysis subgroups.",
          "key_findings": "Single SLE patient with cerebral venous sinus thrombosis and subdural hematoma; improvement after anticoagulant therapy, pulse methylprednisolone, and IVIG; no mention of TXA, trauma, or fibrinolytic phenotypes.",
          "pmid": "33977732",
          "title": "Cerebral venous sinus thrombosis and subdural hematoma in a female patient with systemic lupus erythematosus: a case report and literature review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates safety and effectiveness of distal radial versus transradial access for coronary angiography/intervention. It does not discuss trauma, tranexamic acid (TXA), fibrinolysis, mortality, or subgroup identification based on fibrinolysis rates, so it neither supports nor contradicts the proposed mechanism about optimizing TXA benefit in trauma.",
          "key_findings": "Distal radial access (DRA) for coronary angiography or intervention showed similar access success and puncture-site hematoma rates compared to traditional transradial access (TRA), but significantly lower radial artery occlusion and spasm rates, indicating DRA is a safe and effective access route for coronary procedures.",
          "pmid": "34867106",
          "title": "Safety and Effectiveness of Coronary Angiography or Intervention through the Distal Radial Access: A Meta-Analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses sleep disordered breathing, cardiac arrhythmias, and their mechanisms, but does not mention trauma, tranexamic acid (TXA), fibrinolysis, or subgroup identification related to CRASH-2. It neither supports nor contradicts the proposed mechanism about optimizing TXA use based on fibrinolysis rates in trauma patients.",
          "key_findings": "Sleep disordered breathing (including obstructive sleep apnea and Cheyne-Stokes respiration) is common in cardiac disease, associated with worse prognosis, promotes structural myocardial changes, and is linked to increased frequency of cardiac arrhythmias; treating SDB may reduce arrhythmic risk, but more randomized trial data (especially for CSR) are needed.",
          "pmid": "21344358",
          "title": "[Sleep disordered breathing and cardiac arrhythmias: mechanisms, interactions, and clinical relevance].",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract reports on udenafil therapy and exercise performance in Fontan patients and does not involve tranexamic acid (TXA), trauma, fibrinolysis, or subgroup stratification by fibrinolysis rates. Therefore it neither supports nor contradicts the proposed mechanism regarding TXA benefit optimization in trauma based on fibrinolysis status.",
          "key_findings": "In the FUEL trial, udenafil 87.5 mg twice daily in adolescents with Fontan physiology did not significantly improve peak oxygen consumption but did improve several measures at ventilatory anaerobic threshold; no changes were seen in myocardial performance index, reactive hyperemia index, or BNP. No data presented relate to trauma, TXA, or fibrinolytic activity.",
          "pmid": "31736357",
          "title": "Results of the FUEL Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses cardiovascular toxicities of CAR T-cell therapy and their association with cytokine release syndrome, not trauma, fibrinolysis, tranexamic acid (TXA), or subgroup identification based on fibrinolysis rates. It neither supports nor contradicts the idea that subgroups with higher fibrinolysis could optimize benefit from TXA in trauma.",
          "key_findings": "Cardiovascular events occur in 10\u201336% of CAR T-cell therapy patients, associated with higher grades of cytokine release syndrome and often preceded by elevated troponin; mechanisms of left ventricular dysfunction from CAR T therapy remain unknown.",
          "pmid": "33937946",
          "title": "Cardiovascular Toxicities of CAR T-cell Therapy.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on electrocardiographic alterations and prognostic outcomes in acute non-traumatic brain injury. It does not discuss tranexamic acid (TXA), fibrinolysis, trauma populations, or subgroup identification based on fibrinolytic activity, so it neither supports nor contradicts the proposed mechanism regarding optimizing TXA benefit via high-fibrinolysis subgroups in trauma.",
          "key_findings": "ECG abnormalities are common after acute non-traumatic brain injury and may predict poor outcomes, including neurogenic pulmonary edema, delayed cerebral ischemia, ventricular dysrhythmias, and in-hospital death; QT dispersion has an unclear association with mortality.",
          "pmid": "37736801",
          "title": "Electrocardiogram alterations in non-traumatic brain injury: a systematic review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses catecholamine responses and sympathetic activation during hypoxia and high altitude, not trauma, fibrinolysis, or tranexamic acid (TXA). It does not examine TXA use, trauma populations, fibrinolytic phenotypes, or mortality outcomes, so it neither supports nor contradicts the idea that identifying subgroups with higher fibrinolysis could optimize TXA benefit in trauma.",
          "key_findings": "Hypoxia activates sympathetic nervous system via chemoreceptors, but many laboratory studies showed no change in plasma/urinary noradrenaline and limited increases in adrenaline; microneurography showed increased muscle sympathetic nerve activity. At high altitude (>1 week), most field studies showed increased noradrenaline, with lesser changes in adrenaline. Short-term high-altitude exposure in unacclimatized subjects did not increase, and even temporarily reduced, plasma catecholamines, possibly due to increased clearance or reduced synthesis (e.g., oxygen sensitivity of tyrosine hydroxylase). These findings are about catecholamine dynamics in hypoxia, not TXA or fibrinolysis in trauma.",
          "pmid": "9578385",
          "title": "Catecholamines, hypoxia and high altitude.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract concerns ultrasound guidance for vascular access in coronary angiography and its effect on access success and vascular complications. It does not involve tranexamic acid (TXA), trauma, fibrinolysis, or subgroup identification based on fibrinolytic status, so it neither supports nor conflicts with the proposed mechanism related to optimizing TXA benefit in trauma via fibrinolysis-based subgroups.",
          "key_findings": "Ultrasound-guided arterial access increased first-attempt success and reduced venipuncture compared with manual access in coronary angiography, with no significant difference in vascular complications like hematoma, pseudoaneurysm, or bleeding.",
          "pmid": "37683581",
          "title": "Ultrasound Guidance for Vascular Access for Coronary Angiogram: A Meta-Analysis of Randomized Controlled Trials.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract studies 4-aminopyridine and Hebbian stimulation to enhance neuronal activity and motor recovery after chronic spinal cord injury. It does not involve trauma-related hemorrhage, fibrinolysis, tranexamic acid (TXA), or subgroup identification based on fibrinolysis rates, so it neither supports nor conflicts with the proposed TXA mechanism.",
          "key_findings": "In a randomized design, participants with chronic spinal cord injury received either 4-AP or placebo plus Hebbian stimulation and standard rehab; the 4-AP group showed significantly greater and sustained improvements in walking speed, endurance, corticospinal excitability, and light touch sensation, suggesting 4-AP can potentiate Hebbian stimulation effects on motor recovery.",
          "pmid": "40126943",
          "title": "Combinatorial approaches increasing neuronal activity accelerate recovery after spinal cord injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses sympathetic ophthalmia, its pathogenesis, imaging, and immunosuppressive/biologic treatments. It does not mention tranexamic acid (TXA), trauma-related fibrinolysis, mortality, or identification of subgroups with higher fibrinolysis rates. Therefore it neither supports nor contradicts the proposed mechanism about optimizing TXA use in trauma based on fibrinolysis levels.",
          "key_findings": "Sympathetic ophthalmia is a rare bilateral granulomatous panuveitis following ocular trauma or surgery; diagnosis is aided by multimodal imaging; treatment is primarily corticosteroids and immunosuppressive agents, with TNF-\u03b1 blockers and other biologics as emerging options.",
          "pmid": "35579612",
          "title": "Sympathetic Ophthalmia - An Overview.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines the safety and efficacy of perioperative esmolol, a beta-1 blocker, in noncardiac surgery and does not involve tranexamic acid (TXA), trauma patients, fibrinolysis, or subgroup identification based on fibrinolytic activity. Therefore it neither supports nor contradicts the proposed mechanism about optimizing TXA benefit in trauma via identifying high-fibrinolysis subgroups.",
          "key_findings": "Perioperative esmolol in noncardiac surgery increased unplanned hypotension (OR 2.13; 95% CI 1.48\u20133.04), did not significantly increase significant bradycardia (OR 1.18; 95% CI 0.69\u20132.02), and reduced the frequency of myocardial ischemia in seven studies (OR 0.17; 95% CI 0.02\u20130.45). Effects on MI or stroke were not assessed due to low event rates.",
          "pmid": "21127279",
          "title": "The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "ihr",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Patients with a high heart rate at admission often require prompt hemostatic treatment intervention, and TXA is known to be more effective when administered promptly within bleeding contexts.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND (\"heart rate\" OR \"initial heart rate\" OR tachycardia OR bradycardia OR pulse) AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"administered\" OR \"intervention\" OR \"hemostatic\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses maternal tachycardia as a diagnostic sign of clinical chorioamnionitis and postpartum hemorrhage risk, as well as management with antibiotics and uterotonics, but it does not mention tranexamic acid (TXA), hemostatic interventions, or any relationship between admission heart rate and the timing or effectiveness of TXA or other hemostatic treatments.",
          "key_findings": "Maternal tachycardia is listed as one of the clinical criteria for suspected chorioamnionitis; clinical chorioamnionitis is associated with postpartum hemorrhage and often managed with oxytocin and uterotonics; standard treatment focuses on intrapartum antibiotics (e.g., ampicillin, gentamicin, cephalosporins, macrolides). No data are presented linking high heart rate at admission to the need for prompt hemostatic treatment or to the effectiveness or timing of TXA.",
          "pmid": "38233317",
          "title": "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates bleeding outcomes and factor XI inhibition with abelacimab versus rivaroxaban in atrial fibrillation, but does not mention heart rate at admission, timing of hemostatic intervention, acute bleeding scenarios, or TXA use. Therefore, it neither supports nor contradicts the proposed mechanism about high admission heart rate indicating need for prompt hemostatic treatment and the time-sensitive effectiveness of TXA.",
          "key_findings": "Abelacimab, a factor XI\u2013targeting monoclonal antibody, given monthly reduced free factor XI levels by ~97\u201399% and significantly lowered major or clinically relevant nonmajor bleeding compared with rivaroxaban in atrial fibrillation patients. The trial was stopped early due to greater-than-anticipated bleeding reduction; adverse event profiles were similar between groups. No data on acute bleeding, heart rate, or TXA are reported.",
          "pmid": "39842011",
          "title": "Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares DOACs versus LMWH for prevention of recurrent VTE and bleeding in cancer patients. It does not report on heart rate at admission, urgency or timing of hemostatic intervention, or the effectiveness or timing of TXA administration. Thus, it neither supports nor contradicts the proposed mechanism about high heart rate indicating need for prompt hemostatic treatment and the time-dependent effectiveness of TXA.",
          "key_findings": "DOACs were noninferior to LMWH for preventing recurrent VTE over 6 months in cancer patients; major bleeding rates were similar between groups and did not meet the noninferiority criterion for bleeding. No data are provided on heart rate, acute hemostatic management, or TXA use/timing.",
          "pmid": "37266947",
          "title": "Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses clinical signs of UGIB including tachycardia and outlines general initial management (resuscitation, PPIs, endoscopy timing, endoscopic hemostasis), but it does not mention tranexamic acid (TXA), its timing, or its differential effectiveness based on heart rate at admission. Therefore, it neither supports nor contradicts the proposed mechanism about prompt TXA use in patients with high heart rate.",
          "key_findings": "Upper GI bleeding can present with tachycardia to shock; initial treatment focuses on fluid and blood resuscitation, early endoscopic evaluation within 24 hours, IV proton pump inhibitors, and various endoscopic hemostatic methods (injection, thermal, mechanical). TXA and its time-sensitive effectiveness are not discussed.",
          "pmid": "39150279",
          "title": "Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on outcomes of transcatheter tricuspid-valve replacement versus medical therapy in severe tricuspid regurgitation. It does not discuss heart rate at admission, the timing of hemostatic interventions, or the use or timing of tranexamic acid (TXA), so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Transcatheter tricuspid-valve replacement improved a composite outcome (including mortality, functional status, quality of life, and 6-minute walk distance) compared with medical therapy alone, but was associated with higher rates of severe bleeding and need for permanent pacemakers. No data are presented on admission heart rate, hemostatic treatment strategies, or TXA administration.",
          "pmid": "39475399",
          "title": "Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines the effect of walking on blood pressure and resting heart rate in generally hypertensive or at-risk adults, not acutely bleeding patients. It does not involve hemostatic treatment, tranexamic acid (TXA), emergency settings, or the impact of admission heart rate on the timing or effectiveness of TXA. Although it reports that walking reduces heart rate, this is in a chronic lifestyle context and is not linked to acute bleeding management or TXA efficacy, so it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "Meta-analysis of 73 RCTs (n=5763) shows that walking interventions reduce systolic blood pressure (MD about -4 mmHg), diastolic blood pressure (MD about -1.8 mmHg), and resting heart rate (MD about -2.8 bpm) across age and sex groups in non-acute settings.",
          "pmid": "33630309",
          "title": "Walking for hypertension.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns the relationship between high admission heart rate, the urgency of hemostatic intervention, and the time-dependent effectiveness of tranexamic acid (TXA). This trial evaluates prehospital blood products (PRBC + lyophilised plasma) versus saline in traumatic haemorrhagic shock. Although it notes that most patients received TXA and that time to treatment matters in traumatic haemorrhage, it does not analyze outcomes by heart rate, does not assess the interaction between heart rate and hemostatic treatment timing, and does not evaluate the time-dependent efficacy of TXA specifically. Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "In a randomized phase 3 trial of 432 adults with trauma-related haemorrhagic shock, prehospital PRBC + lyophilised plasma was not superior to 0.9% sodium chloride for the composite outcome of mortality or impaired lactate clearance (64% vs 65%; adjusted risk difference -0.025%, 95% CI -9.0 to 9.0; p=0.996). About 90% of participants received tranexamic acid before randomisation. The study does not report outcomes stratified by heart rate at admission, nor does it analyze the time-dependent effect of TXA on outcomes.",
          "pmid": "35271808",
          "title": "Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses fetal heart rate changes and management of acute fetal hypoxia in obstetrics, not patient heart rate at admission in bleeding contexts or the timing/effectiveness of tranexamic acid (TXA). It does not address hemostatic treatment, TXA use, or any relationship between high admission heart rate and the need for or effectiveness of TXA.",
          "key_findings": "The abstract describes: (1) pathophysiology of acute vs gradually evolving fetal hypoxia; (2) fetal heart rate responses (catecholamine-mediated tachycardia vs vagally mediated bradycardia); (3) definitions and clinical implications of prolonged decelerations and terminal bradycardia; (4) recommended obstetric interventions (urgent birth, intrauterine resuscitation, tocolysis) and audit of bradycardia-to-delivery intervals. No mention is made of TXA, hemostatic therapy, or high heart rate at admission as an indicator of such therapy.",
          "pmid": "37270260",
          "title": "Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates safety and efficacy of catheter-directed low-dose fibrinolysis for pulmonary embolism, focusing on RV/LV ratio, pulmonary pressures, thrombus burden, and bleeding events. It does not report admission heart rate, timing of hemostatic treatment relative to presentation, or the effectiveness of tranexamic acid (TXA), nor does it analyze how high heart rate influences the need for or response to hemostatic therapy.",
          "key_findings": "Ultrasound-facilitated, catheter-directed low-dose tPA for acute massive and submassive PE reduced RV/LV diameter ratio, pulmonary artery systolic pressure, and thrombus burden, with low rates of major bleeding and no intracranial hemorrhage. No data are presented on heart rate at admission, promptness of hemostatic intervention, or TXA use or efficacy.",
          "pmid": "26315743",
          "title": "A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns high heart rate at admission indicating need for prompt hemostatic intervention and the time-dependent effectiveness of tranexamic acid (TXA) in bleeding contexts. The abstract instead evaluates music therapy effects on pain, anxiety, and vital signs (including heart rate) after cardiac valve replacement, with no mention of bleeding, hemostasis, TXA, or timing of hemostatic therapy. Thus it neither supports nor contradicts the specific TXA-related mechanism.",
          "key_findings": "In a randomized controlled trial of 86 post\u2013cardiac valve replacement patients, a 15-minute music intervention given three times, in addition to standard care, led to statistically significant reductions over time in pain, anxiety, systolic blood pressure, heart rate, and respiratory rate compared with standard care alone, with no significant change in diastolic blood pressure.",
          "pmid": "36650441",
          "title": "Music therapy for pain and anxiety in patients after cardiac valve replacement: a randomized controlled clinical trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines music therapy effects on blood pressure, heart rate, and anxiety in older adults with hypertension, not trauma or bleeding scenarios, does not involve tranexamic acid (TXA), hemostatic interventions, or timing of pharmacologic treatment relative to high admission heart rate. Thus it neither supports nor contradicts the proposed mechanism about prompt TXA use in patients with high heart rate at admission in bleeding contexts.",
          "key_findings": "Music therapy in older adults with hypertension led to significant reductions in systolic blood pressure, heart rate, and anxiety compared with controls, and was described as a safe, noninvasive, nonpharmacological, and cost-effective intervention.",
          "pmid": "35312440",
          "title": "Music Therapy as an Intervention to Reduce Blood Pressure and Anxiety Levels in Older Adults With Hypertension: A Randomized Controlled Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates safety and efficacy of ApTOLL (a TLR4 antagonist) in ischemic stroke patients undergoing endovascular treatment, focusing on outcomes like mortality, infarct volume, and disability. It does not mention heart rate at admission, hemostatic treatment, tranexamic acid (TXA), timing of TXA administration, or any relationship between heart rate and hemostatic intervention efficacy. Therefore, it neither supports nor conflicts with the proposed mechanism.",
          "key_findings": "ApTOLL 0.2 mg/kg given within 6 hours of ischemic stroke onset along with endovascular treatment was associated with lower mortality, reduced NIHSS scores at 72 hours, smaller final infarct volume, and better 90-day functional outcomes compared with placebo, with an acceptable safety profile. No data on heart rate, hemostatic therapy, or TXA are reported.",
          "pmid": "37338893",
          "title": "Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares apixaban versus aspirin in subclinical atrial fibrillation patients stratified by CHA2DS2-VASc score and reports stroke/systemic embolism and major bleeding rates. It does not mention heart rate at admission, acute bleeding, timing of hemostatic treatment, or tranexamic acid (TXA), so it neither supports nor contradicts the proposed mechanism about prompt TXA effectiveness in patients with high heart rate and active bleeding.",
          "key_findings": "Apixaban reduced stroke/systemic embolism but increased major bleeding compared with aspirin in patients with device-detected subclinical atrial fibrillation, with net benefit varying by CHA2DS2-VASc score strata (<4, =4, >4). No data on heart rate, acute hemostatic intervention, or TXA use are provided.",
          "pmid": "39019530",
          "title": "Apixaban vs Aspirin According to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Subclinical Atrial\u00a0Fibrillation: Insights From ARTESiA.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses indications, goals, and outcomes of resuscitation thoracotomy in traumatic arrest and refractory shock, focusing on blood pressure, trauma type, and CPR duration. It does not mention heart rate at admission, timing or use of tranexamic acid (TXA), or any relationship between admission heart rate and the effectiveness or urgency of hemostatic treatment.",
          "key_findings": "Resuscitation thoracotomy is indicated for traumatic cardiac arrest with specific CPR duration thresholds and for refractory shock with systolic blood pressure <65 mm Hg; reported overall survival is 12%, with different survival rates by trauma type. No data on heart rate, TXA use, or temporal effectiveness of hemostatic interventions are presented.",
          "pmid": "28941568",
          "title": "Resuscitation thoracotomy.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares percutaneous left atrial appendage closure with warfarin for stroke prevention in atrial fibrillation and reports efficacy and safety outcomes. It does not address heart rate at admission, bleeding contexts, timing or effectiveness of tranexamic acid (TXA), or prompt hemostatic interventions. Therefore it neither supports nor contradicts the proposed mechanism about high heart rate and TXA effectiveness in bleeding.",
          "key_findings": "Percutaneous LAA closure was non-inferior to warfarin for the composite endpoint of stroke, cardiovascular death, and systemic embolism, with a rate ratio of 0.62 (95% CrI 0.35\u20131.25). Primary safety events (major bleeding, pericardial effusion, device embolisation) were more frequent in the intervention group (RR 1.69, 95% CrI 1.01\u20133.19), largely due to periprocedural complications. No data are presented on heart rate at admission, acute bleeding management, or TXA use.",
          "pmid": "19683639",
          "title": "Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses autonomic dysfunction and heart rate-related assessments after intracerebral hemorrhage but does not address high heart rate at admission as an indicator for prompt hemostatic intervention, nor does it mention tranexamic acid (TXA) or the timing of hemostatic therapy. Thus it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "The review describes: (1) frequent occurrence of autonomic dysfunction after intracerebral hemorrhage due to damage in central autonomic network structures; (2) associations of autonomic dysfunction with outcomes such as cardiac complications, blood pressure fluctuations, infection, and metabolic disturbances; (3) use of measures like heart rate variability, baroreflex sensitivity, and plasma catecholamines to assess autonomic function; and (4) the idea that targeting autonomic dysfunction and restoring sympathetic\u2013parasympathetic balance may improve outcomes. It does not address TXA, hemostatic treatments, or specific prognostic implications of high admission heart rate for hemostatic therapy.",
          "pmid": "38372446",
          "title": "Autonomic dysfunction and treatment strategies in intracerebral hemorrhage.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares distal versus traditional radial access for coronary procedures, focusing on radial artery occlusion, access failure, and local bleeding/hematoma. It does not address patient heart rate at admission, timing of hemostatic treatment, tranexamic acid (TXA), or the relationship between prompt treatment and TXA effectiveness in bleeding contexts. Therefore, it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Distal radial access (DRA) vs traditional radial access (TRA) showed: lower radial artery occlusion risk (RR 0.36), higher vascular access failure risk (RR 2.38), and no significant difference in bleeding or hematoma rates.",
          "pmid": "36182561",
          "title": "A Meta-Analysis of Traditional Radial Access and Distal Radial Access in Transradial Access for Percutaneous Coronary Procedures.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses transfusion-related lung complications (circulatory overload and TRALI), their mechanisms, incidence, and management. It does not mention heart rate at admission, timing or effectiveness of tranexamic acid (TXA), or prompt hemostatic interventions in bleeding patients. Therefore, it neither supports nor contradicts the proposed mechanism about high heart rate signaling need for prompt hemostatic treatment and TXA\u2019s time-dependent effectiveness.",
          "key_findings": "The abstract reports that (1) circulatory overload results from hypertransfusion leading to pulmonary edema, particularly in very young or elderly patients; (2) transfusion-related acute lung injury (TRALI) is an ARDS-like syndrome with 5\u201314% mortality, occurring within 1\u20132 hours of transfusion of plasma-containing products; (3) TRALI is mainly mediated by passively transfused complement-activating HLA or granulocyte-specific antibodies that cause granulocyte aggregation and microvascular pulmonary injury; and (4) management includes respiratory support, with most patients recovering within 96 hours. No data are presented regarding heart rate at admission, bleeding management, or TXA administration.",
          "pmid": "11499976",
          "title": "Transfusion and lung injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates the efficacy and safety of high-dose TXA in reducing blood loss during adolescent idiopathic scoliosis surgery, but it does not report on patients\u2019 heart rate at admission, the timing of TXA administration relative to onset of bleeding, or any interaction between initial heart rate and TXA effectiveness. Therefore it neither supports nor contradicts the proposed mechanism about high heart rate and prompt hemostatic intervention.",
          "key_findings": "High-dose intravenous TXA significantly reduced blood loss in adolescent idiopathic scoliosis surgery without increasing thromboembolic events; no data on admission heart rate, urgency of intervention, or time-to-TXA were provided.",
          "pmid": "33446219",
          "title": "The efficacy and safety of high-dose tranexamic acid in adolescent idiopathic scoliosis: a meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares cardiovascular and bleeding outcomes between transulnar and transradial access for coronary procedures. It does not discuss patient heart rate at admission, timing of hemostatic treatment, use or timing of tranexamic acid (TXA), or how prompt administration in bleeding contexts affects outcomes. Therefore, it neither supports nor contradicts the proposed mechanism about high heart rate prompting early TXA use and its effectiveness.",
          "key_findings": "Transulnar access was associated with lower local access site bleeding but higher crossover rates compared to transradial access, with no differences in in-hospital mortality, major adverse cardiovascular events, arterial spasm, large hematoma, or procedural parameters. No data on heart rate, TXA use, or timing of hemostatic intervention were reported.",
          "pmid": "37352671",
          "title": "Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "Injury Severity Score (ISS)",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "TXA acts primarily on suppressing fibrinolysis, but severe injuries often involve multifaceted coagulopathy, including consumption of clotting factors and impaired fibrinogen function, which TXA may not effectively address.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"Injury Severity Score (ISS)\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"coagulopathy\" OR \"multifaceted\" OR \"fibrinolysis\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 4,
      "support_count": 1,
      "conflict_count": 0,
      "neutral_count": 3,
      "support_percentage": 25.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.25,
      "abstracts_analyzed": [
        {
          "stance": "support",
          "confidence": "medium",
          "reasoning": "The proposed mechanism states that TXA mainly suppresses fibrinolysis, while trauma-induced coagulopathy also involves deficits such as fibrinogen depletion that TXA does not address. This trial shows that early, targeted fibrinogen supplementation with coagulation factor concentrates (primarily fibrinogen concentrate) was superior to FFP in reversing severe clotting failure and reducing rescue therapy and massive transfusion requirements. The authors explicitly conclude that early and effective fibrinogen supplementation is important in severe trauma coagulopathy. This supports the notion that correcting fibrinogen-related defects (and broader factor deficiencies) is critical beyond merely modulating fibrinolysis, in line with the mechanism that TXA alone would be insufficient for multifaceted coagulopathy.",
          "key_findings": "In trauma patients with ROTEM-defined coagulopathy, first-line treatment with coagulation factor concentrates, primarily fibrinogen concentrate (50 mg/kg), led to significantly fewer patients requiring rescue therapy (4% vs 52% with FFP; OR 25.34, p<0.0001) and a lower need for massive transfusion (12% vs 30% with FFP; OR 3.04, p=0.042). The study was stopped early due to futility and safety concerns in the FFP arm. The authors conclude that early and effective fibrinogen supplementation is important for severe clotting failure in multiple trauma, highlighting the importance of addressing fibrinogen and coagulation factor deficits in trauma-induced coagulopathy.",
          "pmid": "28457980",
          "title": "Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract characterizes early trauma-induced coagulopathy as predominantly hypercoagulable with frequent shortened R time and infrequent hyperfibrinolysis, but it does not discuss tranexamic acid (TXA), its mechanism of action, or compare fibrinolysis-focused treatment against other components of coagulopathy such as clotting factor consumption or fibrinogen dysfunction. Thus it neither supports nor contradicts the proposed mechanism about TXA\u2019s limited effectiveness in multifaceted coagulopathy.",
          "key_findings": "In high-acuity trauma patients, 83% showed abnormal TEG on admission; most had shortened reaction (R) time indicating a hypercoagulable state driven by thrombin generation; hyperfibrinolysis was detected in only 8% of patients; abnormalities were similar across injury severity groups.",
          "pmid": "25264646",
          "title": "Defining early trauma-induced coagulopathy using thromboelastography.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines dextran\u2019s effects on immune function, monocyte activity, and coagulation/hypercoagulability in trauma patients, focusing on plasminogen activator, procoagulant activity, and fibrinopeptide A. It does not involve tranexamic acid (TXA), nor does it compare fibrinolysis-focused treatment with broader coagulopathy mechanisms such as clotting factor consumption or impaired fibrinogen function. Therefore, it neither supports nor contradicts the specific proposed mechanism about TXA\u2019s limited role in multifaceted trauma coagulopathy.",
          "key_findings": "Low molecular weight dextran was infused in trauma patients and compared to standard treatment alone. Outcomes included immune reactivity, monocyte plasminogen activator and procoagulant activity, and intravascular fibrinopeptide A as a marker of coagulation. Significant immune and coagulation abnormalities occurred only in patients with ISS >25, and in ISS 25\u201335, all control and some dextran patients showed immune and monocyte perturbations. No data on TXA, its antifibrinolytic action, or its adequacy in the context of complex coagulopathy are provided.",
          "pmid": "2412002",
          "title": "Dextran as a modulator of immune and coagulation activities in trauma patients.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines trauma-related activation of coagulation and fibrinolysis and the effect of IFN-gamma on these markers but does not mention tranexamic acid (TXA) or compare antifibrinolytic effects with other components of trauma-induced coagulopathy such as clotting factor consumption or impaired fibrinogen function. Therefore it neither supports nor contradicts the specific mechanism proposed for TXA.",
          "key_findings": "In severely injured patients, markers of coagulation activation and fibrinolysis were elevated after injury and decreased over time in survivors; IFN-gamma therapy increased inflammatory cytokines (TNF-alpha, IL-6) but did not change coagulation or fibrinolytic parameters compared with placebo.",
          "pmid": "9620360",
          "title": "Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gamma.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "Injury Severity Score (ISS)",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Severe injuries are often associated with systemic inflammatory responses and acidosis that predict poor clot formation and function, reducing the efficacy of TXA.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"Injury Severity Score (ISS)\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"inflammatory\" OR \"associated\" OR \"responses\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 20,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 20,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates the accuracy of viscoelastic haemostatic assays (TEG6s) to predict massive transfusion needs in trauma patients. It does not examine systemic inflammatory responses, acidosis, clot formation/function in relation to injury severity, nor the efficacy of tranexamic acid (TXA), and therefore does not provide evidence for or against the proposed mechanism.",
          "key_findings": "Abnormal viscoelastic haemostatic assay results had moderate sensitivity (73.6%) and low specificity (49.3%) for predicting massive transfusion at 24 hours; the Citrated Functional Fibrinogen component had higher specificity (86.9%) for rule-in; combining VHA with existing decision scores improved prediction performance. No mention is made of systemic inflammation, acidosis, or TXA efficacy.",
          "pmid": "40275305",
          "title": "Utility of point of care viscoelastic haemostatic assays for trauma patients in the emergency department.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract discusses prehospital care strategies, airway management, intravenous access, and infusion therapy in polytrauma, but it does not address systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of tranexamic acid (TXA). There is no mechanistic or clinical evaluation of how injury-induced inflammation or acidosis might affect coagulation or TXA effectiveness.",
          "key_findings": "Early on-scene airway management (intubation) is associated with improved late prognosis (reduced MOF); intravenous access should be obtained early; the optimal amount of prehospital infusion is unclear; on-scene therapy and improved rescue systems have reduced early posttraumatic death. These findings are unrelated to systemic inflammation/acidosis effects on clot function or TXA efficacy.",
          "pmid": "9248540",
          "title": "Prehospital care, importance of early intervention on outcome.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns systemic inflammatory responses and acidosis impairing clot formation and TXA efficacy. The abstract focuses on hypocalcaemia in trauma patients, its association with transfusion, and ionized calcium levels on arrival. It does not assess systemic inflammation, acidosis, clot formation/function, or TXA efficacy, nor does it link hypocalcaemia to TXA response. Therefore it neither supports nor contradicts the specific proposed mechanism.",
          "key_findings": "In trauma patients (ISS \u226515), mean ionized calcium on arrival was 1.08 mmol/L, indicating hypocalcaemia is common. Patients without prehospital transfusion had similar mean iCa (1.07 mmol/L), while transfused patients had a slightly lower arrival iCa (mean difference \u22120.03 mmol/L). The authors question citrate-induced hypocalcaemia as the sole explanation and note that the clinical impact of this small iCa difference remains unclear.",
          "pmid": "38319350",
          "title": "Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products: a systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "medium",
          "reasoning": "The abstract reports that nonsurvivors with trauma-induced ARDS had greater base deficit and lower pH (acidosis) along with coagulopathy markers (higher INR, lower platelets), but it does not mention tranexamic acid (TXA), clot formation quality, or TXA efficacy. While the findings are consistent with systemic inflammatory response and acidosis in severely injured patients, the study does not link these abnormalities to TXA performance or clot function outcomes, so it neither supports nor contradicts the specific mechanism about reduced TXA efficacy.",
          "key_findings": "Among trauma ARDS patients, nonsurvivors had higher injury severity scores, higher INR, lower platelet counts, greater base deficit, lower temperature, lower GCS, and lower pH compared with survivors.",
          "pmid": "36525023",
          "title": "Experience With Trauma-Induced ARDS: A Retrospective Study of US Wartime Casualties 2003-2015.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "medium",
          "reasoning": "The abstract reports that TXA was associated with higher mortality and that any benefit was eliminated in patients with higher transfusion needs, lower systolic blood pressure, operative requirements, and highest injury acuity. However, it does not measure or discuss systemic inflammatory responses, acidosis, or clot formation/function as mediators of TXA efficacy. Thus, it does not directly address the proposed mechanism that inflammation and acidosis impair clotting and reduce TXA effectiveness.",
          "key_findings": "In this retrospective trauma ICU cohort, TXA-treated patients required more packed red blood cells and total fluid, and had higher mortality (27% vs 17%) after propensity matching. The apparent lack of benefit or harm was most evident in patients with higher injury acuity, large transfusion requirements (>2000 mL PRBC), systolic blood pressure <120 mm Hg, or need for emergency surgery. The authors attribute the lack of benefit mainly to rapid availability of fluids and emergency OR, without mechanistic evaluation of systemic inflammation, acidosis, or clot quality.",
          "pmid": "24854303",
          "title": "Do all trauma patients benefit from tranexamic acid?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract analyzes management strategies, timing to revascularization, and amputation outcomes in upper extremity arterial injury, but does not discuss systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of TXA. Therefore it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Among 7908 patients with upper extremity arterial injuries, 68.4% underwent arterial repair, with a median time to repair of 120 minutes. Amputation occurred in 1.8% of patients; blunt and crush mechanisms, concomitant fractures/dislocations, and nerve injuries were associated with amputation. Earlier revascularization within 90 minutes was associated with a decreased amputation rate. No data on systemic inflammation, acidosis, coagulation status, or TXA use/effectiveness are reported.",
          "pmid": "35418267",
          "title": "Contemporary management and time to revascularization in upper extremity arterial injury.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract deals with incidence, fixation methods, and outcomes of posterior pelvic ring injuries associated with straddle fractures. It does not mention tranexamic acid (TXA), systemic inflammatory response, acidosis, or clot formation/function, nor does it analyze how injury severity or systemic responses influence TXA efficacy. Therefore it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Among 73 patients with straddle fractures, 77% had posterior pelvic ring injury; 43 of these were unstable and treated surgically. Mean injury severity score was 24.7. Radiologic and functional outcomes after fixation are reported, but no data on systemic inflammatory responses, acidosis, coagulation status, or TXA treatment or efficacy are provided.",
          "pmid": "32376214",
          "title": "Posterior pelvic ring injury of straddle fractures: Incidence, fixation methods, and clinical outcomes.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates the diagnostic accuracy of FAST in patients with major pelvic fractures and its role in deciding on abdominal exploration. It does not discuss tranexamic acid (TXA), systemic inflammatory responses, acidosis, coagulation status, or clot formation/function, nor any factors that would influence TXA efficacy. Therefore, it neither supports nor contradicts the proposed biological mechanism.",
          "key_findings": "FAST in major pelvic fractures showed pooled sensitivity of 79% and specificity of 90% for detecting significant intra-abdominal hemorrhage; accuracy was 93%. No significant correlation was found between injury severity score and FAST accuracy. The study focuses on imaging-based decision-making for abdominal exploration, not on inflammatory responses, acidosis, coagulation, or TXA efficacy.",
          "pmid": "33149904",
          "title": "FAST accuracy in major pelvic fractures for decision-making of abdominal exploration: Systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract describes injury severity, transfusion needs, hemorrhage control methods, and mortality in open pelvic fractures, but it does not discuss systemic inflammatory responses, acidosis, clot formation or function, or the efficacy of TXA. Therefore it neither supports nor contradicts the proposed mechanism about acidosis-driven poor clot function reducing TXA efficacy.",
          "key_findings": "Patients with open pelvic fractures had high ISS (mean 26.8), large transfusion requirements (mean 13.5 units PRBCs in first 24 h; 79.3% required transfusions), frequent use of angiography and pelvic packing, and high mortality (mean 23.7%). The paper emphasizes bleeding control and transfusion as key management components but does not mention TXA, coagulation status, acidosis, or systemic inflammatory responses.",
          "pmid": "32139131",
          "title": "Management and outcomes of open pelvic fractures: An update.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates blunt adrenal gland injury as a marker of trauma severity and mortality but does not measure systemic inflammatory responses, acidosis, coagulation status, clot quality, or TXA efficacy. Therefore it neither supports nor contradicts the proposed mechanism about inflammation/acidosis impairing clot formation and TXA effectiveness.",
          "key_findings": "Blunt adrenal gland injury (BAGI) is associated with higher Injury Severity Scores and possibly increased in-hospital mortality after sensitivity analysis, with no significant difference in length of stay. The study does not assess systemic inflammation, acidosis, coagulation parameters, or response to TXA.",
          "pmid": "41547883",
          "title": "Impact of blunt adrenal gland injury (BAGI) in major trauma: a systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract analyzes racial disparities, restraint use, injury severity, and outcomes after pediatric motor vehicle crashes. It does not mention tranexamic acid (TXA), systemic inflammatory responses, acidosis, clot formation/function, or how these factors might alter TXA efficacy. Therefore it neither supports nor conflicts with the proposed biological mechanism.",
          "key_findings": "Among pediatric MVC passengers, restraint use was under 50% and was lower among African American, Hispanic, and Native American children. Restraint use was associated with lower Injury Severity Score (ISS) and decreased need for emergency surgery. Higher ISS was associated with increased emergency operations, morbidity, mortality, and longer length of stay. Race/ethnicity did not affect mortality or length of stay on multivariable analysis.",
          "pmid": "22703792",
          "title": "Are there racial disparities in the use of restraints and outcomes in children after motor vehicle crashes?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The proposed mechanism concerns systemic inflammatory responses and acidosis after severe injury impairing clot formation and TXA efficacy. This abstract focuses on citrate-induced hypocalcemia from prehospital plasma, its frequency, and association with survival and massive transfusion. It does not discuss systemic inflammation, acidosis, clot dynamics, or TXA use or efficacy, so it neither supports nor contradicts the specific mechanism.",
          "key_findings": "In two RCTs of prehospital plasma for traumatic hemorrhagic shock, plasma recipients had higher rates of hypocalcemia (ionized calcium \u22641.0 mmol/L) than controls (53% vs 36%; adjusted RR 1.48, 95% CI 1.03\u20132.12). Severe hypocalcemia was independently associated with decreased survival (adjusted HR 1.07, 95% CI 1.02\u20131.13) and increased likelihood of massive transfusion (adjusted RR 2.70, 95% CI 1.13\u20136.46). The study highlights need for calcium supplementation in prehospital plasma protocols but does not address inflammatory responses, acidosis, or TXA-related clot function.",
          "pmid": "32317575",
          "title": "Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines an ICU ABCDEF bundle compliance score, mobility, mortality, and delirium in critically injured patients. It does not measure or report systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of TXA, nor does it discuss how injury-related inflammation or acidosis might influence TXA effectiveness.",
          "key_findings": "Higher maximum daily ABC-123 (ABCDEF bundle) scores and better or improving mobility were associated with reduced mortality and more delirium-/coma-free ICU days in critically injured patients; specific bundle subscores (A\u2013F) showed varying associations with mortality and delirium, but no data were presented on inflammation, acidosis, coagulation status, or TXA response.",
          "pmid": "35343926",
          "title": "Using a real-time ABCDEF compliance tool to understand the role of bundle elements in mortality and delirium.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract analyzes relationships between height of fall, age, and injury severity scores to build mathematical models for estimating fall height. It does not discuss systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of TXA, nor any interaction between injury severity patterns and TXA response.",
          "key_findings": "In 416 fatal falls with known heights, injury severity score (ISS) was significantly correlated with height of fall and age, and regression models showed both were independent determinants of categorized ISS. The work focuses on predicting fall height from injury patterns for investigative purposes, without mentioning coagulation, inflammatory status, acidosis, or TXA.",
          "pmid": "9618909",
          "title": "Fatal falls from a height: the use of mathematical models to estimate the height of fall from the injuries sustained.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates outcomes associated with fibrinogen concentrate use in severely injured, exsanguinating trauma patients but does not assess systemic inflammatory responses, degree of acidosis, clot formation/function, or the efficacy of TXA. Base excess is reported only as a baseline characteristic and not linked to treatment effect or clot quality. No data are presented on TXA use or how acidosis/inflammation modify the effectiveness of any antifibrinolytic therapy. Thus, it neither supports nor contradicts the proposed mechanism about inflammation/acidosis predicting poor clot function and reduced TXA efficacy.",
          "key_findings": "In a matched cohort of severely injured trauma patients (ISS \u226516), fibrinogen concentrate administration was associated with lower 6-hour mortality (10.5% vs 16.7%) and longer time to death but no reduction in overall hospital mortality; multiple organ failure was more frequent in the fibrinogen group. Base excess values at ED arrival were similar between groups (approximately -7.4 to -7.5 mmol/L), but there was no analysis linking acidosis or inflammatory status to coagulation quality or TXA efficacy.",
          "pmid": "23354229",
          "title": "Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on endothelial glycocalyx breakdown (syndecan-1 elevation) and subsequent sepsis risk after trauma. It does not evaluate systemic inflammatory responses or acidosis in relation to clot formation or function, nor does it address TXA efficacy. Therefore it neither supports nor conflicts with the proposed mechanism about acidosis/inflammation predicting poor clotting and reduced TXA effectiveness.",
          "key_findings": "In severely injured trauma patients surviving at least 72 hours, elevated serum syndecan-1 levels (\u226540 ng/mL) measured 4 hours after admission were common (79%) and independently associated with an increased likelihood of developing sepsis, along with higher Injury Severity Score and total blood transfused.",
          "pmid": "30243993",
          "title": "Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on urinary tract infections and asymptomatic bacteriuria in elderly trauma patients, screening practices, and cost-effectiveness. It does not address systemic inflammatory responses, acidosis, clot formation or function, or the efficacy of tranexamic acid (TXA), so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Among elderly trauma patients, 14% had catheter-associated UTI, most present at admission; 14% had asymptomatic bacteriuria at admission; common organisms were E. coli and Enterococcus; screening with urinalysis and culture at admission was found to be cost-effective. No data on coagulation, acidosis, systemic inflammation, or TXA use are reported.",
          "pmid": "26402539",
          "title": "A prospective analysis of urinary tract infections among elderly trauma patients.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates erythropoietin\u2019s effect on mortality in traumatic brain injury patients with varying degrees of extracranial trauma. It does not assess systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of tranexamic acid (TXA). Therefore, it neither supports nor contradicts the proposed mechanism about inflammation/acidosis-related impairment of TXA effectiveness after severe injury.",
          "key_findings": "In a post hoc analysis of the EPO-TBI trial (603 patients), erythropoietin was associated with reduced 6\u2011month mortality in TBI patients with higher extracranial Injury Severity Score (ISS > 6): 6.8% mortality with EPO vs. 17% with placebo (risk reduction 10%, 95% CI 2.9\u201317%, p = 0.007). An interaction between EPO effect and extracranial injury severity was observed (interaction p = 0.048), suggesting potential greater benefit in those with more severe extracranial trauma. No data were reported on systemic inflammation, acidosis, coagulation, or TXA use.",
          "pmid": "28590358",
          "title": "Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines predictors of mortality in flail chest (age and injury severity score) and does not address systemic inflammatory responses, acidosis, clot formation/function, or the efficacy of TXA. Therefore it neither supports nor contradicts the proposed mechanism about inflammation-/acidosis-related impairment of TXA effectiveness.",
          "key_findings": "In flail chest patients, increased age (\u226565 years) and higher injury severity score (ISS \u226531) were identified as independent predictors of mortality; pulmonary contusion, bilateral flail chest, and hospital length of stay were not consistently associated with mortality.",
          "pmid": "26188067",
          "title": "Predictors of mortality in patients with flail chest: a systematic review.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on epidemiology, mechanisms, levels, and outcomes of pediatric cervical spine injuries. It does not discuss systemic inflammatory responses, acidosis, clot formation or function, or the efficacy of TXA, so it neither supports nor contradicts the proposed mechanism.",
          "key_findings": "Describes mechanisms of pediatric cervical spine injury (motor vehicle accidents, sports, falls), injury levels (C1\u2013C4 vs C5\u2013C7), presence of SCIWORA, associated closed head injury, injury severity scores, and mortality predictors (younger age, high ISS, CHI, C1 dislocations). No data on coagulation, inflammatory markers, acidosis, or TXA use/effectiveness.",
          "pmid": "11479837",
          "title": "Cervical spine injuries in children: a review of 103 patients treated consecutively at a level 1 pediatric trauma center.",
          "analysis_method": "llm"
        }
      ]
    },
    {
      "feature_name": "Injury Severity Score (ISS)",
      "mechanism": {
        "mechanism_type": "biological",
        "description": "Data suggests that the hemostatic response in severe polytrauma is different from isolated, less complex injuries where TXA has more pronounced effects.",
        "evidence_level": "moderate"
      },
      "query": "(trauma OR \"tranexamic acid\" OR TXA OR bleeding OR hemorrhage) AND \"Injury Severity Score (ISS)\" AND (\"pathophysiology\" OR \"mechanism\" OR \"causal\" OR \"etiology\" OR \"interaction\") AND (\"hemostatic\" OR \"polytrauma\" OR \"pronounced\") AND (Clinical Trial[PT] OR Review[PT] OR Meta-Analysis[PT])",
      "total_abstracts": 8,
      "support_count": 0,
      "conflict_count": 0,
      "neutral_count": 8,
      "support_percentage": 0.0,
      "conflict_percentage": 0.0,
      "support_ratio": 0.0,
      "abstracts_analyzed": [
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract evaluates REBOA as a hemostatic/temporizing intervention in severe torso hemorrhage and reports mortality, hemodynamics, transfusion needs, and complications. It does not discuss tranexamic acid (TXA), compare hemostatic responses between polytrauma and isolated injuries, nor address differences in TXA effect size by injury complexity. Therefore it neither supports nor contradicts the proposed mechanism about differential TXA effects in severe polytrauma.",
          "key_findings": "REBOA use in severe non-compressible torso hemorrhage was associated with improved 24-hour survival (RR 0.46) but no difference in in-hospital mortality (RR 0.99), a nonsignificant improvement in systolic blood pressure (~55.8 mmHg higher post-occlusion), lower packed RBC requirements (mean difference \u22123.02 units), and a nonsignificant increase in post-procedural complications. No data on TXA or comparisons of hemostatic response between polytrauma and isolated injuries are presented.",
          "pmid": "35307763",
          "title": "Impact of resuscitative endovascular balloon occlusion of the aorta (REBOA) in traumatic abdominal and pelvic exsanguination: a systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The review describes overall patterns and temporal changes in causes of death in polytrauma patients, particularly a reduction in hemorrhage-induced deaths, but it does not examine hemostatic response characteristics, compare severe polytrauma to isolated injuries, or assess TXA effects. Therefore it neither supports nor contradicts the proposed mechanism about differing hemostatic responses and TXA efficacy.",
          "key_findings": "In level 1 trauma centers from 1980\u20132008, CNS injury remained the predominant cause of death, followed by exsanguination, sepsis, and multi-organ failure. A decrease in hemorrhage-induced deaths (from about 25% to 15%) was observed over the last decade of the review period, with improvements attributed to imaging (multislice CT), ATLS implementation, and emergency logistics, not to specific hemostatic mechanisms or TXA-related effects.",
          "pmid": "19540488",
          "title": "Patterns of mortality and causes of death in polytrauma patients--has anything changed?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on epidemiology, injury severity (AIS/ISS), and clinical outcomes (ICU admission, chest tube insertion, mortality) in polytrauma patients with blunt chest trauma. It does not examine hemostatic responses, coagulation parameters, or the effects of tranexamic acid (TXA), nor does it compare hemostatic responses between severe polytrauma and isolated injuries. Therefore it neither supports nor contradicts the proposed mechanism about differential hemostatic response and TXA effect.",
          "key_findings": "In 110 polytrauma patients with blunt chest injury, higher thoracic AIS was associated with increased need for chest tube insertion and ICU admission, but not with ICU length of stay, intubation days, complications, or mortality. Management involved mostly conservative treatment with early chest tube when indicated, pain control, and physiotherapy. No data on hemostasis or TXA use/effects were reported.",
          "pmid": "28427480",
          "title": "Lessons from a large trauma center: impact of blunt chest trauma in polytrauma patients-still a relevant problem?",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract compares retroperitoneal packing versus angioembolization for hemorrhage control in severe pelvic trauma, focusing on timing, transfusion needs, complications, and mortality. It does not examine tranexamic acid (TXA), hemostatic response differences between severe polytrauma and isolated injuries, or any pharmacologic modulation of coagulation. Therefore, it neither supports nor contradicts the proposed mechanism about differential TXA effects in severe polytrauma.",
          "key_findings": "In 56 hemodynamically unstable pelvic fracture patients (ISS \u226533), pelvic packing had shorter time to intervention (77 vs 102 min) and shorter procedure time (60 vs 84 min) than angioembolization, with similar 24-hour PRBC transfusion requirements (5.2 vs 6.4 units) and mortality (4 vs 5 deaths). No differences in complications were observed between groups. TXA use and specific hemostatic response patterns were not reported.",
          "pmid": "26508436",
          "title": "Retroperitoneal packing or angioembolization for haemorrhage control of pelvic fractures--Quasi-randomized clinical trial of 56 haemodynamically unstable patients with Injury Severity Score \u226533.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract focuses on imaging (whole-body CT) strategies, injury severity scoring, and resuscitation logistics in polytrauma, without discussing hemostatic responses, tranexamic acid (TXA), or differences between polytrauma and isolated injuries in terms of coagulation or TXA effect.",
          "key_findings": "Whole-body CT reduces mortality by about 25% compared to selective CT in patients with ISS \u226516; ISS is a good indicator of injury severity but available only after diagnosis; dose-reduced WB-CT protocols are recommended for certain patients; WB-CT is valuable even during ongoing resuscitation. No data on hemostasis or TXA are presented.",
          "pmid": "31925467",
          "title": "[Update polytrauma and computed tomography in ongoing resuscitation : ABCDE and \"diagnose first what kills first\"].",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract deals with blunt adrenal gland injury as a marker of severe polytrauma and its association with injury severity and mortality, but it does not mention tranexamic acid (TXA), hemostatic response, or any comparison of coagulation behavior between severe polytrauma and isolated/less complex injuries. Therefore it neither supports nor contradicts the proposed mechanism about differential hemostatic response and TXA effect.",
          "key_findings": "Blunt adrenal gland injury (BAGI) is associated with higher Injury Severity Score and, on sensitivity analysis, higher in-hospital mortality, but not with longer hospital length of stay; BAGI is suggested as an indicator of severe polytrauma. No data are presented on TXA use, coagulation parameters, or hemostatic response patterns.",
          "pmid": "41547883",
          "title": "Impact of blunt adrenal gland injury (BAGI) in major trauma: a systematic review and meta-analysis.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "medium",
          "reasoning": "The abstract evaluates outcomes of fibrinogen concentrate administration in severely injured, exsanguinating trauma patients but does not examine or compare the hemostatic response in severe polytrauma versus isolated or less complex injuries, nor does it address TXA effects. Therefore it does not directly support or contradict the proposed mechanism about differing hemostatic responses and TXA efficacy by injury complexity.",
          "key_findings": "In a matched cohort of severely injured trauma patients (ISS \u226516), early fibrinogen concentrate use was associated with lower 6-hour mortality (10.5% vs 16.7%), longer time to death (7.5 vs 4.7 days), increased multiple organ failure (61.2% vs 49.0%), similar overall hospital mortality (28.6% vs 25.5%), and a non-significant trend toward more thromboembolism. No data on TXA or comparison with isolated/less complex injuries was provided.",
          "pmid": "23354229",
          "title": "Administration of fibrinogen concentrate in exsanguinating trauma patients is associated with improved survival at 6 hours but not at discharge.",
          "analysis_method": "llm"
        },
        {
          "stance": "neutral",
          "confidence": "high",
          "reasoning": "The abstract examines hemostatic activation and inflammation after severe injury and the effect of IFN-gamma therapy, but it does not compare hemostatic responses between severe polytrauma and isolated/less complex injuries, nor does it evaluate tranexamic acid (TXA) or its efficacy. Therefore it does not directly support or contradict the proposed mechanism about differential TXA effects in severe polytrauma versus simpler injuries.",
          "key_findings": "In severely injured patients (ISS \u226520\u201325), markers of coagulation activation and fibrinolysis were elevated after trauma and declined over time in survivors; IFN-gamma therapy increased TNF-alpha and IL-6 levels relative to placebo but did not alter coagulation or fibrinolytic markers compared with placebo. The study concludes that trauma is associated with hemostatic activation and that IFN-gamma at the studied dose is safe with respect to coagulation/fibrinolysis.",
          "pmid": "9620360",
          "title": "Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gamma.",
          "analysis_method": "llm"
        }
      ]
    }
  ]
}